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SUMMARY
The main aims of the work reported in this thesis were to assess, using 
laboratory techniques, the clinical feasibility of the currently popular concept of 
immediate cell seeding of prosthetic vascular grafts, and to compare the 
cell/prosthesis interaction of two cell types which have been recommended for 
this purpose.
The thesis describes a series of laboratory studies investigating several 
aspects of immediate seeding of cultured adult human endothelial and 
mesothelial cells onto ePTFE vascular graft material.
A comparison was made beween mechanical and enzymatic harvesting of 
adult human endothelial cells from segments of long saphenous vein. The 
enzymatic method, using collagenase, virtually always succeeded in releasing large 
numbers of cells, which subsequently grew to confluence and could be 
subcultured thereafter through several passages. The mechanical technique 
consistently failed to provide sufficient viable cells to grow in culture. A 
technique for harvesting microvascular endothelial cells from subcutaneous and 
omental fat was assessed, but success using this method was limited.
t
Endothelial cells, derived enzymatically from long saphenous vein, and 
mesothelial cells, derived enzymatically from omentum removed at laparotomy, 
were grown in culture. Comparison was made of the growth characteristics of 
these two cell types on the substrates fibronectin, type 4 collagen, laminin (all 
basement membrane extracellular matrix proteins), basement membrane gel, and 
uncoated culture flasks. Basement membrane gel proved unsatisfactory for the 
growth to confluence of both cell types. Both endothelial and mesothelial cells 
grew equally well on all the other substrate proteins, although the former 
required special growth supplements in the medium, whereas the latter did not. 
Endothelial cells failed to thrive on uncoated culture flasks, whereas mesothelial 
cells grew well on this surface. Both cell types had similar life spans in culture.
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A series of experiments was performed in order to assess the time course 
of attachment of the two cell types to standard tissue culture polystyrene. 
Fibronectin coating of the culture surface gave the most rapid attachment of both 
cell types, with laminin giving the poorest adhesion rates. Irrespective of 
substrate coating used, the majority of attached cells had become adherent within 
one hour of plating. Mesothelium attached more slowly to all substrates than 
endothelium.
The ability of cultured endothelial and mesothelial cells to attach to 
uncoated, protein coated, and "pre-clotted" ePTFE after 1 hour's incubation was 
assessed using two different techniques. Adhesion to this surface was slower than 
to tissue culture polystyrene, irrespective of the pre-treatment used, but, again, 
fibronectin coating gave the highest average attachment efficiency. The most 
consistent attachment rates, however, were obtained using pre-clot as the 
substrate for seeding, although average attachment was marginally lower.
Scanning electron microscopy of all the endothelial seeded protein coated 
specimens demonstrated large numbers of attached and flattened cells, but with 
large areas of exposed ePTFE, irrespective of seeding density. Pre-clotted 
specimens demonstrated virtual complete coverage after 1 hour’s incubation, if a 
high seeding density of cells was used. Attached cells were at various stages of 
spreading. Although Scanning electron microscopy of mesothelial cell seeded 
specimens showed many attached cells, these were mostly rounded up, only a 
small number being fully spread.
The conclusion from these findings is that pre-clotted blood is the best 
substrate with which to line ePTFE prior to seeding with endothelial cells. If 
seeding cell density is sufficiently high, this treatment enables the surface to form 
a confluent monolayer of cells within a period of one hour. Pre-coating with 
extracellular matrix proteins is patchy, and results in incomplete cell coverage.
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The microvascular harvesting technique requires further development as a means 
of greatly improving cell yields.
Mesothelial cells attach to ePTFE more slowly than adult endothelial cells, 
whether the surface is pre-coated with protein or pre-clotted with whole blood.
An artificial flow circuit was then designed, in order to subject seeded cells 
to a shear stress similar to that which would be experienced in vivo. ePTFE graft 
segments were pre-clotted with whole blood and seeded with endothelial cells as 
in the earlier experiments, the graft segments then being inserted into the flow 
circuit and exposed to flow for 60 minutes. Cell retention during the period of 
flow was assessed quantitatively by means of indium-lll-oxine labelling of the 
cells, and the post-flow appearance of the endothelial monolayer was examined 
by scanning electron microscopy.
Apart from an initial cell loss immediately after commencing flow through 
the endothelialised graft segments, the cell loss during the 60 minutes flow was 
low at each of three different flow rates assessed (25, 100 and 200 ml/minute). 
Scanning electron microscopy demonstrated persistence of a virtually intact 
monolayer after 60 minutes of flow at these flow rates.
It is concluded that, once endothelial cells are attached to pre-clotted 
ePTFE grafts, the cell/substrate and substrate/graft bond is sufficiently strong to 
resist the shear stress likely to be encountered when such a graft is implanted in 
vivo.
CHAPTER 1 
SMALL CALIBRE VASCULAR GRAFTS 
THE NEED FOR IMPROVEMENT
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1.1. Introduction
Peripheral vascular disease secondary to atherosclerosis continues to 
present a major health problem in the Western world, estimates suggesting the 
presence of symptomatic disease in as many as 2-3 per cent of males aged 45-60, 
and 1% of females aged 50-65 in the United Kingdom (Boobis & Bell 1982). 
Although, as with any pathological condition, the best cure is prevention, it will 
undoubtedly be many years before the complexities of the aetiology and the 
factors affecting the natural history of atherosclerosis are resolved, thereby 
permitting effective preventive measures. Efforts are still therefore required to 
identify adequate means of treating the already established, and symptomatic 
disease.
Although many patients with Fontaine stage 2 disease improve 
significantly with conservative measures, such as stopping smoking, losing weight, 
taking more exercise and avoiding fat and cholesterol in their diets (Imparato et 
al 1975), there are those with more severe ischaemia in whom these measures are 
less effective, and disabling claudication may progress to rest pain and gangrene. 
As attempts to influence the natural history of peripheral vascular disease by 
pharmacological means have to date been universally unsuccessful (Boobis & Bell 
1982), the only means of relieving symptoms in a large number of these patients 
and, in many cases avoiding amputation, remains surgical bypass.
Since the turn of the century, when surgeons first became seriously 
interested in the concept of replacing or bypassing occluded arteries, they have 
been striving to identify the ideal arterial substitute. Although many biological 
and synthetic materials have been evaluated for this purpose, many of which 
perform well when applied to the large diameter intra-abdominal arteries, most 
have proved unsatisfactory when applied to small diameter, low flow situations 
such as those pertaining below the inguinal ligament. By far the most satisfactory 
material in this regard is autogenous vein, which has been found to give
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satisfactory limb salvage and long term patency rates when used to bypass 
femoro-popliteal occlusions (Mehta 1979). Because of this, autogenous vein has 
tended to be the "gold standard" against which all other graft performances are 
compared.
In recent years there has been a growth of interest in the concept of 
promoting endothelialisation within prosthetic graft surfaces, an idea which was 
initially conceived following the observation that prosthetic grafts in human 
subjects consistently fail to develop an endothelial lining, other than perhaps a 
few "islands" throughout the length of the graft (Sauvage et al 1975). This 
represents a fundamental difference between prosthetic and autogenous venous 
grafts, and may contribute in a large way to the discrepancy between the results of 
the different graft types.
The justification for continuing research into developing a better vascular 
prosthesis may be illustrated by a brief review of the many possible alternatives 
which have been assessed over the last 40 years or so.
1.2 Autogenous Vein as an Arterial Substitute
The early pioneering work concerning the use of vein to replace diseased 
or occluded arteries was carried out at the beginning of the present century. 
Although there were several individual reports of successful grafting in a variety 
of different arteries (Gluck 1898; Goyanes 1906; Lexer 1907), the first definitive 
work on the subject was that of Alexis Carrel, who developed basic suturing 
techniques and demonstrated, by detailed histological follow-up of veins 
implanted into animal models, the histological changes of "arterialisation" which 
begin almost immediately following exposure of vein to arterial pressures (Carrel 
1906).
Further reports of clinical success followed (Bemheim 1916; Murray 
1941), but it was only after Kunlin, in 1949, described the use of reversed
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saphenous vein to bypass arterial obstructions, that the use of vein as a 
replacement artery came into widespread use (Kunlin 1949).
There subsequently followed a number of reports describing satisfactory 
results using this technique to save lower limbs which were otherwise facing 
amputation. Dale, for example, reported a limb salvage rate of 65% in 41 
patients undergoing femoropopliteal bypass for severe ischaemia, and Ray et al. 
described a salvage rate of 77.5% in 40 patients with disease of similar severity 
(Dale 1967; Ray et al 1970). The latter authors' overall long term patency rate, 
including those procedures which were carried out for claudication only, was 
84.6%. Some of the successful grafts occurred despite the presence of very low 
flow rates and poor radiological run-off, leading to the conclusion that the rate of 
flow required to maintain patency in an autogenous vein graft is low. Tyson and 
Reichle in 1972 similarly reported good results, with a limb salvage rate of 51 out 
of 70 femoro-tibial bypasses for severe ischaemia (Tyson and Reichle 1972).
More recently, long term patencies of up to 72% at 5 years have further 
demonstrated the suitability of autogenous vein as an arterial substitute, although 
the success rate does to some extent depend on the severity of the disease, those 
with rest pain and gangrene tending to do less well than those with intermittent 
claudication (Mehta 1979; Veith et al 1986).
As the above results have not been bettered by any graft material 
subsequently assessed, most vascular surgeons would consider autogenous vein as 
the first choice conduit for femoro-popliteal or more distal bypass.
1.3 Alternatives to Saphenous Vein
The problem presented by the 30% or so of cases in which there is no 
suitable long saphenous vein has been addressed by many workers throughout the 
history of vascular replacement surgery, and, to date, no completely satisfactory 
solution has been found.
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Broadly speaking, three approaches have been taken:
a. Utilise some other form of "biological" conduit. Into this category falls 
arterial and venous homografts, arterial heterografts, and the mandril technique 
investigated by Sparks and other workers in the early 1970's.
b. Develop a synthetic material which has chemical properties which 
render it sufficiently thromboresistant to support the low rates of blood flow often 
encountered within smaller calibre vascular grafts, and which may be responsible 
for their failure. This approach included a variety of measures to induce an 
electrical charge across the wall of the graft, and attempts to bond heparin within 
the graft structure.
c. Develop a synthetic material which, when made into a vascular graft and 
implanted, would allow endothelium to grow along the graft lumen from the ends, 
and possibly also through the substance of the graft from ingrowth of connective 
tissue capillaries, working on the premise that if a naturally lined biological 
material was not available, then the next best thing is, logically, a conduit which is 
still lined by the physiologically normal blood-surface interface. This was the 
basis for the development of the porous arterial graft.
a. Biological Arterial Substitutes
Biological grafts include alternative autogenous veins, arterial and venous 
homografts, heterografts, autogenous "fibro-collagenous" tubes and 
glutaraldehyde tanned human umbilical vein.
All of these possible artificial conduits have proved less than ideal, 
although in virtually all cases, initial results were encouraging.
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Arm Veins
Arm veins have not been widely accepted as the solution to the problem, 
mainly because of concern that these veins are rather friable, thin walled and 
difficult to handle, their friability rendering them more susceptible to aneurysm 
formation. Few large series of these grafts exists, however, to confirm or refute 
these difficulties, although Campbell and colleagues reported good patency rates 
using arm veins routinely in the absence of suitable saphenous vein (Campbell, 
D.R. et al 1979).
Arterial and Venous Homografts
In the late 1940's the possibility of using arterial homografts to replace 
diseased arteries received attention. Gross and colleagues demonstrated that all 
cellular elements in homografts disappeared following implantation, the 
homograft thereafter acting purely as a mechanical conduit, rather than a living 
prosthesis (Gross et al 1949). Although initial results were good, as longer term 
results became available a high incidence of late failure and aneurysm formation 
became apparent (Warren 1956; Linton 1958; Meade et al 1966), problems which 
have been attributed to immunologically induced ischaemia and degeneration of 
the graft wall. Attempts to minimise this effect were unsuccessful, and these 
grafts are no longer used.
The possibility of utilising venous homografts for small vessel replacement 
or bypass has also been explored, but clinical experience is sparce and results 
appear to be significantly inferior to those for autogenous vein (Oschner et al 
1971; Tice & Zerbino 1972).
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Heterografts
Bovine heterografts, introduced by Rosenburg in the late 1950's, were also 
associated with difficulties which only became apparent some years after they 
came into use. The problems with these grafts, elucidated by Dale and Lewis, 
were a disturbingly high rate of early and late thrombosis, an unacceptibly high 
infection rate, and an aneurysm rate of 5% (Dale & Lewis 1976). These grafts 
were also difficult to re-explore on account of their soft and non-resistant wall.
Fibrocollagenous Tubes
Peirce introduced the concept of the fibro-collagenous tube as an arterial 
conduit in 1953. The channels resulting from the presence of polyethylene tubes 
in the rectus sheaths of dogs for a period of five weeks were found to give good 
patency rates when implanted as canine aortic grafts. Histological examination of 
these grafts 12 months after placement revealed a compact fibrous layer with 
circular orientation of collagen bundles, with a thin lining of normal endothelium 
(Peirce 1953). Various modifications to both materials and technique were made 
(Eiken & Norden 1963; Schilling et al 1964) until Sparks applied the process 
clinically in the early 1970's. Although Sparks' results were good (Sparks 1973) 
long term patency rates were poor, and an inordinately high complication rate, 
especially aneurysm formation, subsequently became apparent, precluding these 
grafts from further clinical use (Hallin & Sweetman 1976). An additional 
problem with these grafts was that a period of some weeks was required for 
maturity to be reached, obviously a disadvantage in cases of critical ischaemia.
Human Umbilical Vein Grafts
In 1976, Herbert Dardik described the use of human umbilical veins, 
removed from the cord and "tanned" by treatment with glutaraldehyde (Dardik et 
al 1976). By 1980, Dardik's group had amassed experience of the use of 552 such
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grafts implanted in patients. They found 5 year cumulative patency rates of 60% 
in the femoropopliteal position, the 4 year patencies in the femorotibial and 
femoroperoneal positions being 38% and 28% respectively (Dardik et al 1982). 
These grafts were found to be biocompatible, nonantigenic and mechanically 
equivalent to artery, the most consistent feature of which is a continuous internal 
elastic membrane, but without an endothelial lining.
The conclusion reached by Dardik and his co-workers was that these grafts 
gave long term results equivalent to those for autogenous vein. Unfortunately, 
these results have not been duplicated by other authors, and the human umbilical 
vein graft has not displaced saphenous vein as the first choice arterial substitute 
(Bergan et al 1982). With increasing experience of these grafts, concern over the 
incidence of aneurysm formation has recently arisen (Nevelsteen et al 1987).
Conclusions
Investigation of all the above possible solutions to the problem of 
developing an ideal biological arterial graft has therefore fallen short of providing 
the answer. Although, in theory, one might expect the best vascular conduits to 
be biological in origin, most of these grafts are plagued by poor long term patency 
rates, or prohibitively high complication rates. One major factor contributing to 
the consistent superiority of autogenous vein may be the lack of a viable 
endothelial lining on any of the alternatives.
b. Prosthetic Vascular Grafts
Other workers, realising the potential usefulness of having available "off 
the shelf' artificial grafts, turned their attention to developing a suitable synthetic 
graft material. The first attempt to bridge an arterial defect with a prosthetic 
graft was by Alexis Carrel in 1912, an attempt which failed (Carrel 1912). It was 
not until some years later that the true potential of prosthetic grafts was realised.
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In this field, two approaches have been taken. One was to attempt to 
develop a material which, although it would never endothelialise, would be 
intrinsically anti-thrombogenic enough to resist occlusion by thrombosis. The 
alternative was to try to manufacture grafts in such a way as to encourage 
ingrowth of the patient's own endothelium, working on the assumption that 
endothelium is the optimal surface to support blood moving at the slow rates of 
flow occurring in small calibre graft situations.
Non-thrombogenic Surface
The first of these approaches has to date met with limited success, since all 
prosthetic surfaces so far evaluated possess an inherent thrombogenicity. 
Attempts to minimise this by passing an electrical current through them, by 
carbon coating, and by bonding heparin into their structure, each gave good early 
experimental results (Sharpe et al 1965; Sharpe et al 1966; Sharpe et al 1968; 
Scott et al; Hufnagel et al 1967). Unfortunately, each has fundamental problems 
which have to date precluded its routine use in human subjects.
The Ideal Neointima
In 1951 Voorhees made the incidental observation that a piece of silk 
suspended in the heart of a dog developed an endothelial-like lining. This 
stimulated investigation into a number of materials constructed in a porous 
fashion, to establish whether their porous nature would allow eventual 
endothelialisation of the inner surface. Voorhees carried out a series of canine 
aortic replacements using "Vinyon N" cloth, and reported promising results with 
regard to patency rates and behaviour of the graft wall as judged by histological 
examination after removal at varying time intervals. Voorhees found that the 
grafts developed a smooth transparent lining composed of multiple layers of 
flattened cells and collagen fibres. In addition, there appeared to be no foreign
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body reaction, and fibroblasts were observed growing in through the interstices of 
the material (Voorhees et al 1952).
These results led to the investigation of alternative substances, the major 
ones being Dacron, Orion, Ivalon sponge, and Teflon. In 1958 Harrison reported 
the results of a series of aortic, femoral, and carotid replacements using these 
materials, and concluded that the only satisfactory results were obtained when 
Teflon was used for large vessel replacement, none of these substances 
performing well in the case of arteries less than 5 mm in diameter (Harrison 
1958).
As a result of his investigations, which involved histological examination of 
the grafts at varying intervals up to 6 months post implantation, Harrison 
proposed the following events during the process of "healing" of prosthetic graft 
materials:
1. A fibrous tissue capsule develops outside the graft, gradually becoming 
adherent.
2. A layer of fibrin is deposited on the inner surface. This is initially 
loosely attached, and gradually increases in thickness, to 1-3 mm at three weeks, 
depending on the graft material used.
3. The fibrin lining is gradually replaced by fibrous tissue growing in 
through the interstices of the graft.
4. Healing occurs when the graft is lined by a smooth glistening surface, 
grossly similar to the host intima, but composed of a flattened layer of fibrous 
tissue.
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Although the above sequence of events seems to occur in all species 
studied, Sauvage and colleagues have demonstrated an enormous variation in the 
speed and completeness of "healing", being very rapid in the pig, calf and baboon, 
and extremely slow in man (Sauvage et al 1974). If complete "healing" is defined 
as including endothelialisation of the luminal surface as suggested by Sauvage, 
then complete healing has never been observed in man, although in many animal 
species endothelialisation does eventually occur along the length of the graft. In 
humans, endothelial coverage generally extends only for a maximum of 6-10 mm 
"pannus ingrowth" from either anastomosis. More extensive coverage than this is 
rare and patchy (Sauvage et al 1975). "Healing" in the context of human 
prosthetic vascular grafts therefore refers simply to the organisation of the rapidly 
deposited fibrinous layer, with its eventual replacement with fibrous tissue, this 
then being referred to as the "neo-intima".
Despite modifications to Dacron and Teflon designed to encourage 
endothelial ingrowth and maximise attachment of the "neo-intima", no 
endothelialisation resulted, although knitted grafts did show improved connective 
tissue ingrowth with stronger anchoring of the neo-intima than was the case with 
their woven counterparts. The addition of an internal velour surface helped this 
attachment even further, but failed to promote endothelialisation.
The importance of porosity was emphasised by Wesolowski, who in 1961, 
on the basis of the results of 350 graft implantations into animals, concluded that 
porosity is the one most important factor determining the outcome of a graft 
procedure, the more porous the graft, the higher the chance of developing a 
viable neo-intima (Wesolowski 1961).
1.4. Prosthetic Grafts Applied to Small Diameter Vessels
Although all the above graft materials perform well when applied to large 
diameter, high flow situations such as aorto-iliac replacement (Papadopoulos
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1976), their performance when used for small vessel bypass is very much inferior 
to that for autogenous vein, the average cumulative patency for Dacron used in 
the femoro-popliteal situation, for instance, being in the region of 42% at 5 years, 
in comparison to a rate of approximately 65% at 5 years when saphenous vein is 
used (Mehta 1979).
Jacobson, in 1963, suggested, on the basis of a series of canine grafts, 
ranging from 1-4 mm in diameter, and 3-4 cm in length, that prosthetic grafts 
should not be used for vessels less than 4 mm in diameter (Jacobson et al 1963). 
He based this statement on the finding of 100% patency when arterial 
homografts, arterial autografts, or venous autografts were used, as opposed to a 
patency rate of 0% in the case of prosthetic grafts. This figure was somewhat 
improved if the diameter of the prosthesis was made 2-3 times the diameter of the 
vessel it replaced, but even then, patency rates were poor, at 20% and 62% 
respectively.
Several clinical studies have confirmed the disappointing performance of 
Dacron grafts in the small vessel situation, with 5 year patency rates varying from 
10% to 50% (Reinhold et al 1979; Szilagyi et al 1965). The poor results reported 
by most authors applied irrespective of the type of Dacron used (knitted, woven, 
velour).
1.5. Prosthetic Graft Occlusion
In order to improve prosthetic graft performance, it is clearly relevant to 
consider possible reasons for prosthetic graft failure. Esquivel and Blaisdel, in a 
review of the reasons for prosthetic graft failure, stated that "the characteristics of 
the graft lining are probably the most critical factors in the outcome of a vascular 
prosthesis", the other main reasons for failure being blood alterations and 
decreased flow through the graft (Esquivel & Blaisdel 1986). Apart from the
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inherent thrombogenicity of all prosthetic materials, the phenomenon of neo- 
intimal hyperplasia contributes to a large extent to the failure of the grafts. 
Although the exact cause of this condition is as yet unknown, the most popular 
theory is that the process is due to a combination of factors, including compliance 
mismatch, anastomotic turbulence, and release of platelet derived growth factors 
which stimulate proliferation of smooth muscle cells.
As the first hours and days after implantation are important in determining 
the subsequent performance of an arterial graft, the events occurring when the 
surface comes into contact with flowing blood are of crucial significance. 
Irrespective of the actual graft material used, the reactions occurring between a 
newly implanted synthetic vascular graft and the circulating blood are relatively 
consistent, and commence almost immediately the graft material is exposed to the 
circulation. The relative importance of each of the events and the ultimate fate of 
the graft depend to a large extent on the physico-chemical properties of the 
material, the presence or absence of anticoagulant and the velocity of the blood 
flow through it. This latter factor depends on the length and diameter of the 
conduit and also the quality of the distal "run off' vessels.
1.6. Blood-Surface Interactions
The initial event, occurring within the first few seconds of exposure of 
blood to a synthetic surface, is the absorption of blood proteins, notably 
fibrinogen, into the substance of the material. This stimulates the attachment of 
platelets, which in turn stimulates platelet release reactions, setting in motion the 
enzyme cascade leading to fibrin formation. The presence of fibrin leads to the 
adherence of more platelets, which undergo release reactions, and thus a "viscious 
cycle" is set up, with subsequent growth of the platelet-fibrin aggregate (Bartlett 
& Anderson 1982).
31
In the absence of any anticoagulant activity the above reaction proceeds to 
the development of a macroscopic clot. In a prosthesis of large diameter, with 
arterial blood flowing rapidly through it, the surface clot is constantly "washed 
clean", and patency maintained until the graft "heals" by the ingrowth of fibrous 
tissue and capillaries. If, on the other hand, the diameter of the graft is small, and 
the rate of flow through it slow, then the resulting clot may become large enough 
to result in graft occlusion.
These events are modified by the presence of anticoagulant to the extent 
that the platelet aggregates are not "glued together" by the formation of fibrin, 
and are much less adherent to the graft surface. Small micro-emboli are 
therefore more likely, leading to a reduction in platelet survival time, but without 
clinical relevance.
Other factors which then come into play in determining the long term fate 
of the graft are the thickness of the neo-intima and the development of pseudo- 
intimal hyperplasia at the anastomoses. Neo-intimal thickness depends directly 
on the porosity of the graft material (Wesolowski et al 1961), while neo-intimal 
hyperplasia, although as yet poorly understood, is believed to result from smooth 
muscle cell stimulation by platelet release factors produced by platelets 
aggregated at the anastomoses.
The presence of endothelium on the luminal surface of prosthetic grafts is 
yet another factor which favourably affects their performance in animal models, 
although this has yet to be achieved in man (Herring et al 1978; Graham et al 
1980). Theoretically, an endothelialised surface should be able to withstand 
much reduced velocities of blood flow better than a prosthetic material or the 
usual "neo-intima". For the reasons described above, an endothelialised surface 
which develops within hours of graft implantation is desirable. Even better would 
be a prosthesis endothelialised at the time of implantation.
32
1.7. Expanded PTFE as a Vascular Prosthesis
1976 saw the introduction to clinical use of expanded
polytetrafluoroethylene (ePTFE), a modification of Teflon with the rather unique 
"nodes and fibrils" structure, and with the favourable property of being 
hydrophobic (and therefore less thrombogenic), as well as microporous. Many 
hopes were raised by Matsumoto's report of 100% patency rates at 4-11 months 
using this material in canine femoral artery replacements, as opposed to a 0% 
patency rate for standard Teflon (Matsumoto et al 1973). Although initial clinical 
results suggested patency rates almost equivalent to those for autogenous vein 
(Campbell, C.D., et al 1979; Veith et al 1978; Burnham et al 1978), more recent 
reports, with longer length of follow-up, have revealed disappointing long term 
patencies when used in the femoropopliteal position, especially in the presence of 
poor distal "run-off' (Klimach et al 1984; Haimov et al 1979; Echave et al 1979). 
As with all grafts, long term results deteriorate, the further distal is the distal 
anastomosis. Mehta, reporting on his statistical analysis of the published 
literature up until 1979, described overall cumulative patencies for ePTFE of 
65% at 3 years in the femoro-popliteal position, and 40% at 2 years in the 
femoro-tibial or femoro-peroneal position. The corresponding figures for 
saphenous vein are 68% and 55% respectively. More recently, Klimach and 
colleagues found 1 year patency rates of 66% for claudicants having ePTFE grafts 
in the femoro-popliteal situation, and only 29% when carried out for pregangrene 
(Klimach et al 1984). A cumulative patency rate of 58% at 2 years was achieved 
in the presence of three vessel "run-off' as opposed to 33% if only one or two 
distal vessels were patent. The 3 year cumulative patency for the entire group 
was only 36%.
Veith and co-workers conducted a randomised trial comparing autogenous 
vein with ePTFE for infra-inguinal arterial grafts. Although patency rates at 2 
years for femoro-popliteal grafts were equivalent, beyond this stage the
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performance of the vein grafts was significantly better, with 4 year cumulative 
patencies of 68% for vein, and 47% for ePTFE (Veith et al 1986).
Although comparison between series is difficult owing to wide differences 
in surgical selection criteria, the general experience of most authors suggests a 
significantly higher rate of late failure of PTFE grafts compared to autogenous 
vein, especially in the presence of risk factors such as poor run off, below-knee 
distal anastomosis, or pre-gangrene as the indication for surgery. Despite this, the 
favourable handling properties of ePTFE, together with its reasonable 
performance in comparison with other graft materials, have made it, for many 
surgeons, the first choice synthetic graft material for use when suitable 
autogenous vein is unavailable (Bergan et al 1982).
1.8. Endothelialisation Within Prosthetic Grafts
None of the above synthetic graft materials, irrespective of porosity or 
structure, has resulted in an endothelialised luminal surface, even after many 
years of implantation. The flow surface of human grafts therefore persists as a 
fibrinous lining. Although the extended duration of patency achieved in some 
cases attests to the fact that fibrin is a reasonably non-thrombogenic surface, the 
persistence of abnormal platelet kinetics in patients with prosthetic vascular grafts 
confirms the continuing thrombogenicity of the prosthetic neo-intimal surface 
(McCollum et al 1981), a factor which may be important in predisposing to failure 
of the graft. The relevance of graft thrombogenicity is confirmed by the 
demonstration of an association between enhanced platelet adhesion and a higher 
failure rate of Dacron femoro-popliteal grafts (Evans & Irvine 1966).
Since the most thromboresistant surface known is endothelium, it seems a 
logical approach to try to achieve a graft lined with this surface. Endothelium 
owes its thromboresistance to the production of a number of actively platelet 
repellant factors, such as ADPase, prostacyclin and a plasminogen activator, as
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well as being a thin, smooth cellular monolayer, the presence of which should 
prevent the sequence of events described above leading to platelet activation and 
ultimate thrombosis.
The reason for the consistent failure of prosthetic grafts to endothelialise 
in human subjects remains elusive, but there exists a widespread belief that, if 
endothelium could in some way be encouraged to grow into and along the 
surface, then the performance of small calibre, low flow grafts would be 
substantially improved, perhaps with the additional benefit that anastomotic neo- 
intimal hyperplasia may be reduced.
1.9 Summary
The present day situation is, therefore, that standard knitted or woven 
Dacron or Teflon, with or without an internal or external velour surface, give 
excellent patency rates when applied to large, high flow arteries, such as the aorta 
or iliacs, but in the case of smaller vessels, such as the femoropopliteal segment, 
these materials give poor results.
Despite extensive research, extending over many years, no completely 
satisfactory small vessel synthetic substitute has been discovered. Of those 
assessed to date, expanded polytetrafluoroethylene has given the most acceptable 
long term patency rates, although most series have found these significantly 
inferior to those of autogenous vein.
One of the main reasons for the consistently poor performance of small 
diameter prosthetic grafts may be the absence of significant endothelial coverage 
of synthetic materials in humans, irrespective of time since implantation. Thus 
the blood in the graft, which may be flowing at a very much reduced rate if distal 
run-off is poor, is constantly being presented with a surface which retains a degree 
of inherent thrombogenicity indefinitely.
CHAPTER 2
ENDOTHELIAL AND MESOTHELIAL CELL SEEDING OF 
PROSTHETIC VASCULAR GRAFTS
35
2.1 Introduction
Human endothelial cells had always proved resistant to growth in culture 
until Jaffe, in the early 1970's, developed a technique for isolating and growing 
human umbilical vein endothelial cells (Jaffe et al 1973). Unfortunately this 
technique was not successful when applied to cells of adult derivation, and it was 
only with the identification of an endothelial cell growth factor (ECGF) derived 
from bovine hypothalamus, together with the demonstration that the growth 
enhancement endowed by this was potentiated by the presence of heparin, that 
long term growth of adult human endothelial cells in culture became possible 
(Maciag et al 1981; Jarrell et al 1984). Recent work, made possible by these 
improvements in cell culture techniques, has revealed a complexity of structure 
and function which had never previously been attributed to endothelial cells, 
whose thromboresistant properties were originally attributed mainly to the 
smoothness of the endothelial monolayer (Ryan & Ryan 1984). It is now 
recognised that healthy endothelium maintains a clot-free surface by the active 
production of thromboresistant secretions, notably ADPase and the arachidonic 
acid derivative prostacyclin, the most potent platelet aggregation antagonist as yet 
identified. In addition, these cells have a complex array of surface enzymes, 
receptors, and transport structures, responsible for a variety of metabolic 
functions. The theoretical benefit of an endothelial lining within prosthetic grafts 
is clear.
With this objective in mind, and disappointed with the potential for 
endothelialisation of all presently available prosthetic graft materials, researchers 
have in recent years directed their efforts to a new approach to this problem, and 
have been attempting to induce endothelial cells to grow inside grafts by 
introducing autogenous endothelium into the graft, either before, or at the time 
of, implantation.
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2.2 Endothelialisation of Prosthetic Graft Surfaces
2.2.1 Endothelialisation by Culture
The idea of "artificially” lining synthetic materials with endothelium was 
first introduced by Mansfield who, in 1975, reported the successful culture of calf 
endothelial cells on 2 different artificial surfaces. The cells, harvested 
enzymatically from carotid artery, were cultured and then seeded into graft 
segments fashioned from the synthetic materials. Following 7 days of culture, 
during which the cells formed a confluent monolayer, the segments were 
implanted as descending aortic replacements in calves. Thromboresistance of the 
cultured endothelial cells was confirmed by incubating cover-slip preparations of 
the cultured cells with platelet rich plasma. Adherence of platelets to the cellular 
monolayer was very much less than to fibroblast controls, confirming the 
thromboresistance of the endothelial cells.
On examining the grafts following their removal from the animals after 
one, four and eight weeks, some of the grafts were found to have a uniform 
endothelial lining at all these time intervals, without adherent thrombus except at 
the anastomotic margins.
Although giving grounds for some optimism, these studies were not carried 
on any further, although the concept of "helping" a graft to endothelialise was 
taken up by other workers. More recently, Foxall and co-workers have 
successfully grown adult human endothelial cells within segments of ePTFE graft 
material by incubation for 18 hours, followed by a period of culture (Foxall et al 
1986). Interesting as these results may be, the practicality of maintaining grafts in 
culture on a routine basis prior to implantation is extremely limited. For this 
reason, most investigators have concentrated on developing a technique of 
immediate seeding i.e. introducing a suspension of cells into the graft lumen at 
the time of surgery, in the expectation that the cells will adhere to the graft wall 
and subsequently proliferate to confluence.
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2.2.2 Seeding Immediately Prior to Implantation
In 1978 Herring, considering a technique of immediate seeding of grafts to 
be of more value, described a method whereby endothelial cells could be 
harvested rapidly from a segment of autogenous vein and seeded immediately 
into a prosthetic graft using pre-clot blood as the seeding medium. In a series of 
experiments using a canine model, he obtained endothelial cells by "scraping" the 
inside of the previously removed saphenous vein. The cells were suspended in 
chilled Sack's solution, and mixed with blood used for pre-clotting the Dacron 
grafts, which were implanted as infra-renal aortic replacements. 12 animals were 
included in the study, six of which received seeded grafts, and six control, 
unseeded grafts. The grafts were removed at 2,4, and 8 weeks after implantation, 
their surfaces compared morphologically and their thrombogenicity assessed. 
The seeded grafts were found to be significantly less thrombogenic than the 
controls, the percentage clot-free surface area was significantly higher in the 
seeded group, and histology revealed an endothelial like lining within seeded 
grafts, there being no evidence of this in the control grafts (Herring et al 1978).
Similar results were obtained by a group from Ann Arbor Michigan, using 
a similar pre-clot seeding technique, but employing an enzymatic method of 
venous endothelial cell harvesting, and maintaining the cells in culture for 14 days 
prior to seeding. The endothelial nature of the lining was confirmed by 
immunofluorescence using factor VIII related antigen (Graham et al 1979; 
Graham et al 1980a).
This same group of investigators subsequently reported a series of 28 
canine thoraco-abdominal Dacron double velour grafts, 14 of which were seeded 
with enzymatically derived venous endothelial cells, the remainder acting as non­
seeded controls. A method of harvesting cells from a length of autogenous 
jugular vein was developed, the cells then being seeded into the graft immediately
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prior to implantation, suspended in the blood used to preclot the graft. The 
authors found that the seeded grafts exhibited greater than 80% endothelial 
coverage after 28 days, with 88.5% clot-free surface, compared to 40.1% clot-free 
area in the control animals (Graham et al 1980b). Histological examination of 
seeded and control grafts at various time intervals from 1-28 days revealed 
endothelial cells becoming visible at 4 days, growing into a virtually confluent 
layer by day 28, representing a coverage of approximately 80%. At this time, 
control grafts showed only a thick fibrin coagulum, with endothelium only in 
limited areas of pannus ingrowth. The authors concluded that endothelial cells 
are relatively resilient, and their seeding onto prosthetic grafts as part of a pre­
clot procedure provides a reasonable environment for continued growth.
The first attempt to seed ePTFE grafts was made in 1982 by the Ann 
Arbor group, again using the canine model, with cultured external jugular venous 
endothelial cells (Graham et al 1982). 91% endothelial coverage resulted after 4 
weeks, compared to 10% in control animals. In contrast to seeded Dacron grafts, 
ePTFE did not regularly demonstrate a subendothelial layer, and the authors 
speculated that this may adversely affect the durability of the monolayer. In an 
attempt to overcome this problem, Kempczinski implanted specially made ePTFE 
grafts, with an increased porosity of 45 microns, and without the external "wrap" 
present on standard ePTFE grafts, in the expectation that the increased porosity 
would allow improved connective issue ingrowth (Kempczinski et al 1985). Those 
which were seeded with autologous enzymatically harvested cells developed a 
confluent endothelial lining within 7 weeks, while unseeded controls did not. In 
addition, endothelialised grafts contained a 75-100 micron subendothelial lining.
All of the above studies confirmed that the concept of endothelial cell 
seeding of prosthetic grafts was sound, at least in the context of the canine model. 
Further work confirmed these findings and also demonstrated improved
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cumulative patency rates in seeded as opposed to non-seeded canine Dacron 
thoraco-abdominal grafts (Stanley et al 1982).
This stimulated many other workers to begin investigations into various 
aspects of the seeding process.
2.3 The Evidence for Reduced Thrombogenicity of Seeded Grafts
Many studies, using a variety of approaches, have demonstrated that the 
seeding process results in the attainment of a monolayer which is intact 
functionally, as well as morphologically, at least so far as thromboresistant 
properties are concerned.
The original studies by Herring's group assessed thrombogenicity by 
performing clotting tests on the luminal surface of the graft after sacrifice of the 
animal.
Clagett demonstrated both an accelerated return to normal platelet 
survival figures (PST), and a normal level of prostacyclin production by the graft 
lumen, in dogs which received seeded Dacron grafts, compared to non-seeded 
controls. Examination of removed grafts revealed a close correlation between 
degree of endothelial coverage and normalisation of PST (Clagett et al 1984).
A further study, utilising controlled flow studies on bilateral canine carotid 
interposition grafts, one side seeded and the other unseeded, demonstrated 
increased patency rates and increased thrombus free surface areas in seeded 
grafts following a period of four hours' exposure to reduced flow rates (Hunter et 
al 1983).
Graft thrombogenicity after endothelial seeding has also been examined 
using the technique of radioactive isotope labeled platelet imaging (Whitehouse 
et al 1983). This study suggested a high correlation between a negative scan and 
completeness of endothelialisation, and revealed a significant difference in the 
rapidity with which the scans in the seeded and nonseeded groups became
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negative. 100% of those in the seeded group were negative by eight weeks, as 
opposed to only 50% in the controls, suggesting complete lack of thrombogenicity 
in seeded grafts by eight weeks.
2.4 Harvesting of Endothelial Cells
One area of doubt which confronted the initial investigators, and is still a 
matter of some controversy, is the best method of harvesting endothelial cells - in 
other words, which of the currently available ways of stripping the inner layer of 
cells ensures the highest possible yield of viable endothelial cells, but at the same 
time avoids significant contamination with other cell types, such as smooth muscle 
cells and fibroblasts.
Harvesting techniques can be broadly classified into two groups:-
1. mechanical
2. enzymatic.
2.4.1 Seeding of Mechanically Harvested Cells
Various methods of mechanically dislodging endothelial cells from donor 
vessels have been used, in various contexts (Herring et al 1982). Herring's 
original work, seeding canine grafts with cells derived from autogenous saphenous 
vein, utilised a technique of "scraping" the exposed endothelial surface of the vein 
with a no. 2 steel wool pledget, this then being rinsed in 2 ml chilled Sack's 
solution to produce a cell suspension (Herring et al 1978).
A similar technique, which has recently been advocated for obtaining 
endothelial cells from stripped varicose long saphenous veins, involves lightly 
drawing a scalpel blade along the inside surface of the vein, and then immersing 
the blade in culture medium to dislodge the attached cells (Ryan and White
1985). Ryan and White claim that cells harvested in this way are capable of 
forming confluent monolayers very quickly.
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Potential Benefits of Mechanical Harvesting
In selecting a mechanical method of harvesting his cells, Herring 
considered the potential benefits to be:-
1. No specialised instrumentation or additional technical staff is
required.
2. No need to remove the cells from the operating field, since no 
centrifugation or processing is required.
3. Mechanical harvesting can be completed fairly quickly.
4. Any potentially toxic effects of enzymes are avoided. This may 
be important, as the long term effect on the cells of exposure to crude 
collagenase, an enzyme contaminated with many other, as yet unidentified, 
proteases, is unknown. It is conceivable that these enzymes may alter cell surface 
proteins sufficiently to interfere with the cell's ability to prevent coagulation.
All of these benefits suggest that mechanical harvesting is potentially more 
practical than the enzymatic alternative. There are, however, some 
disadvantages.
Problems with Mechanical Harvesting
The above harvesting methods have the following potential drawbacks:-
1. Cells derived in these ways tend to occur in large clusters, which may not 
be ideal for promoting an even spread when seeded.
2. Tests of viability of harvested cells have suggested only a 10-20% 
viability rate in the case of those harvested mechanically, as compared to 90% 
viability in those which were derived enzymatically (Slater & Sloan 1975). 
Herring, however, points out that cell viability tests do not always serve as 
accurate predictors of the subsequent behaviour of the cells in culture, and it may
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be that enzymatic treatment is associated with a significant incidence of late cell 
death.
As a result of work reported in 1980, which involved using various lengths 
of vein as a source of mechanically derived endothelium, and calculating the 
minimum surface area of vein to surface area of graft ratio which would result in 
complete graft healing, Herring concluded that this minimum ratio was 0.45. On 
repeating these experiments using an enzymatic harvesting technique, Herring 
obtained identical results, the critical Av/Ag ratio again being 0.45. These 
workers concluded that mechanically and enzymatically harvested cells can be 
seeded with the same efficiency (Herring et al 1980).
3. Mechanical techniques are less selective, and may remove smooth 
muscle cells and fibroblasts in addition to the endothelium.
2.4.2 Seeding of Enzymatically Harvested Cells
Work has also been carried out to develop a suitable enzymatic technique, 
enabling a satisfactory cell yield, but minimising the duration of exposure to the 
potentially toxic enzymes, and reducing contamination with unwanted cell types 
to a minimum.
Graham's group developed a technique whereby the excised vein (in their 
experiments the jugular vein of the dog) was everted over a stainless steel rod and 
exposed sequentially to trypsin and collagenase for ten minutes each. The cells 
were collected by centrifugation of the enzyme solutions, suspended in tissue 
culture medium and then cultured or used for immediate seeding of grafts 
(Graham et al 1980). Using this technique, these workers managed to harvest 0.5 
to 1.5x10  ^cells per 12 cm length of vein as estimated by haemocytometer counts. 
When the cells were cultured confluence was achieved rapidly, and contamination 
with other cell types, specifically smooth muscle cells, was minimal, ie less than 
10% in 2 week cultures.
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Watkins described an alternative technique for harvesting endothelial cells 
from a length of vein (Watkins et al 1984). This involved incubating the 
collagenase-filled vein segment at 37°C for 20 minutes, and then flushing it out 
with culture medium, collecting both the collagenase and the washings, which 
were then spun down to form a cell pellet. These workers showed that the cells 
from a segment of vein of surface area 1.9 cm^ are capable, under favourable 
culture conditions, of multiplying to cover an area equivalent to that of an aortic 
bifurcation graft. Again, contamination with other cell types was minimal (1 
smooth muscle cell nucleus per 100 endothelial nuclei as measured by 
haemocytometer after nuclear staining).
Jarrell has recently described a technique whereby large numbers of 
endothelial cells may be harvested from the capillaries of adipose tissue (Jarrell 
et al 1986). These authors claim cell yields of approximately 10  ^per gram of fatty 
tissue, the cells obtained in this way then growing in vitro, exhibiting the 
morphological and immunological properties of endothelial cells obtained in a 
more conventional way. These cells, when seeded into Dacron pre-clotted with 
platlet rich plasma, attached rapidly and were able to resist shear stress of 0 - 80 
dyne/cm^. If cell yields of this magnitude can be consistently and easily obtained 
by other workers, then this technique is obviously highly attractive from the point 
of view of immediate graft seeding. Macrovascular harvesting releases cell 
numbers which are limited by the length of available vein, whereas the 
microvascular technique would enable very high yields from relatively small 
pieces of tissue.
2.5 Immediate Versus Cultured Seeding
The initial experiments of cell seeding utilised cells cultured prior to 
seeding. While having the obvious advantage of providing a higher seeding cell 
density, this has the disadvantages of requiring an additional operative procedure
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to remove the donor vein, a delay of 2 weeks or so to allow the cells to multiply, 
and, perhaps an increased risk of septic complications. Furthermore, it is 
generally not known in advance which patients are going to require a prosthetic 
graft on account of an unsuitable saphenous vein.
The same problems apply to the idea supported by Foxall, of maintaining 
graft and cells in culture conditions for some days prior to insertion (Foxall et al 
1986). Although these workers succeeded in growing adult human endothelial 
cells to confluence within ePTFE graft segments which had previously been 
coated with collagen and fibronectin, a period of 18 hours' incubation was allowed 
for initial attachment, followed by 1 week's maintenance in culture. The authors 
did not comment on the rapidity of cell attachment and spreading. It is more 
appropriate to develop a technique to enable large quantities of viable cells to 
adhere rapidly to a surface which they find attractive and conducive to rapid 
spreading, in order that a near confluent monolayer may form before the graft is 
exposed to flowing blood.
More recently, Williams has suggested that cells in culture develop a high 
incidence of genetic abnormalities (Williams et al 1987). This obviously raises 
doubts regarding the advisability of implanting cultured cells into patients. For 
these reasons, most workers have sought to identify a means of harvesting cells 
and to develop a means of introducing these into the graft such that sufficient 
numbers will attach to allow proliferation to confluence, the cell to surface bond 
being strong enough to withstand the shear stress of blood flowing past at arterial 
pressures.
2.6 Problems With Immediate Seeding
The obvious question which arises when considering a technique of 
immediate seeding is how the seeded cells and prosthetic surface are likely to 
interact - in other words, will the endothelial cells adhere and spread out upon
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the prosthetic surface rapidly enough to be able to withstand the arterial blood 
flow? When one considers that culture vessels have to be specially manufactured 
to enable cell attachment and growth, it seems unlikely that prosthetic graft 
materials, with their irregular surfaces and porous walls, will be suitable. Some 
modification of the surface is almost certain to be required to permit attachment.
In the early seeding studies this problem was overcome by introducing the 
cells into the graft suspended in blood being used to preclot the graft, such that 
the cells would become caught up in and attach to the fibrinous clot penetrating 
through the interstices of the graft material. While this may be appropriate in the 
case of grafts of Dacron or standard Teflon, which require pre-clotting prior to 
use, the idea of introducing clot into grafts such as ePTFE, which do not normally 
require this treatment, may be considered unwise. In addition, the pre-clotting 
technique has the drawback that many cells will be lost with evacuation of the 
luminal clot prior to graft anastomosis.
The results obtained by the groups of Herring and Graham would, 
nevertheless tend to confirm that autologous clot is satisfactory in this respect, 
although some studies have suggested that one-stage seeding using the pre-clot 
technique is highly inefficient, more cells being lost than actually remain 
adherent. Because of this, a period of 4 weeks or so is required before confluence 
is reached. During this time, the potentially thrombogenic surface of the graft, 
together with the adherent clot, is in contact with the flowing blood.
Jarrell used clotted platelet rich plasma in their experiments involving the 
seeding of microvascular endothelium onto Dacron graft material (Jarrell et al
1986). The Dacron was treated with the plasma prior to introduction of the cell 
suspension, rather than using the plasma as the seeding medium.
The importance of different graft materials in determining the adherence 
of seeded cells is illustrated by the finding of a 70% attachment efficiency for 
Dacron grafts as opposed to an efficiency of only 12% for ePTFE grafts, using
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pre-clotting blood as the seeding medium in each case (Sharefkin at al 1982). 
Despite this, these investigators found that surface coverage at four weeks was 
similar in the two types of graft. This may suggest that, although Dacron may 
take up more cells than ePTFE, those attaching to the latter material may be 
closer to the surface, and therefore in a more favourable position to multiply and 
eventually line the graft surface.
There remains a belief, however, that if cell adherence could be 
maximised, then the time taken for a confluent lining to develop would be greatly 
shortened. This may be of importance, in view of the findings of Campbell that 
seeding of ePTFE grafts does not protect against thrombosis, and, indeed, may 
increase thrombogenic potential until healing occurs (Campbell et al 1984). The 
ideal situation would obviously be a graft on which cells, seeded at confluent 
densities, would form a monolayer rapidly, such that it was complete by the time 
circulation is restored. This would also avoid the dependence on multiple cell 
replications, which may be associated with subsequent genetic damage to the cells 
(Williams et al 1987).
2.7 Extracellular Matrix Proteins as Substrates for Cell Seeding
Recent advances in the understanding of the structure of basement 
membranes, and the ability to isolate many of the components thereof, have led 
to the investigation of many of the "extracellular matrix proteins" with regard to 
their ability to enhance cellular adhesion and growth in vitro (Makarak & 
Howard 1983). It is conceivable that a graft material coated or impregnated with 
one of these proteins may be a more suitable surface for cell attachment than the 
same material simply pre-clotted. The most widely investigated and freely 
available of these is fibronectin, a glycoprotein of molecular weight 440,000, 
found in many situations in vivo, in addition to being a normal component of 
basement membrane.
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2.7.1 Fibronectin
Fibronectin exists in the body in two forms:- soluble, found in plasma, and 
insoluble, found in basement membranes and in loose connective tissue. In 
addition, it is produced by some cells in culture, such as endothelium, fibroblasts 
and smooth muscle cells. The major function of the insoluble, basement 
membrane variety, is thought to be as a substrate for cell attachment, and to act 
as a scaffold for cell movement and migration (Stenman et al 1980).
Several studies have demonstrated that fibronectin coating of cell culture 
vessels and collagenous surfaces significantly increases the number of cells which 
attach to the growth surface thereby decreasing the time required for the culture 
to reach confluence (Martin & Kleinman 1981; Macarak & Howard 1983). 
Fibronectin has also been noted to induce a flattened morphology, as well as 
having an effect on differentiation and migration of the cultured cells (Kleinman 
1980). The fibronectin used for cell culture is generally obtained from human or 
bovine plasma by gelatin-Sepharose chromatography, and both forms are now 
available commercially.
The ability of fibronectin to increase the initial uptake of seeded cells by 
ePTFE prostheses has been assessed in the canine model. Rosenman carried out 
a series of eFIFE carotid replacement grafts in dogs, seeded with endothelial 
cells using autogenous blood clot as the seeding medium (Rosenman et al 1985). 
Using indium- 111-oxine labelling of the seeded cells to indicate cell loss, they 
found a disappointing percentage of cells attached, with only 19.8% adhering 
initially after seeding, 30.8% of these then being dislodged after 30 minutes of 
exposure to the circulation. Ramalanjaona and co-workers, again using isotopic 
labelling of seeded autogenous jugular vein endothelial cells, found that, in canine 
carotid interposition grafts, fibronectin coating increased initial endothelial 
attachment from 19.8% to 46.75% and increased the percentage of seeded cells
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remaining after 24 hours by a factor of 6, from 3.4% to 21.3% (Ramalanjaona et 
al 1986).
Sentissi recently demonstrated that ePTFE grafts, pre-coated with collagen 
and fibronectin, were capable of supporting the growth to confluence of bovine 
aortic endothelial cells. By examining the endothelialised grafts by light and 
scanning electron microscopy after exposure to low and high flow rates for one 
hour in an artificial circulation, they showed that the adherent cells were capable 
of withstanding shear stress with minimal loss. These findings were corroborated 
by using the technique of indium-lll-oxine labelling of the attached endothelial 
cells, which demonstrated an endothelial cell loss rate of 7% at low, and 11% at 
high rates of flow (Sentissi et al 1985). In their discussion, these authors indicated 
that previous studies from. the same centre demonstrated a less than 50% 
attachment rate for endothelial cells to untreated ePTFE, with a subsequent 
decreased amount of DNA at 48 horns compared to 1 hour, indicating that the 
cells did not replicate on untreated ePTFE.
Similar conclusions were reached by Kesler's group who, using endothelial 
cells derived from human umbilical vein, were also able to demonstrate an 
improved strength of adherence of endothelial cells to graft surfaces when coated 
with fibronectin substrate (Kesler et al 1986). 84.9% of inoculated cells adhered 
to fibronectin coated ePTFE grafts, 61.1% remaining attached after 1 hour's 
exposure to an in vitro circulation. Corresponding figures for uncoated ePTFE 
grafts were 52.9% initially, and 1.8% after in vitro circulation. These authors 
found however, that the enhancement of attachment was greater when polyester 
elastomer was the graft material, the percentage retention after 1 hour's exposure 
to an in vitro circulation being 92.1% for these grafts.
In an attempt to estimate the effect of more prolonged exposure to blood 
flow, the same group of workers, using indium-lll-oxine labelling of the seeded 
cells, estimated the retention of canine endothelial cells by ePTFE and polyester
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elastomer grafts after 1 and 24 hours implantation as carotid replacements 
(Kesler et al 1986). Although retention prior to perfusion was the same with both 
types of graft, after perfusion for both these time intervals retention was 
significantly better in the polyester elastomer grafts. 93.3% of cells seeded into 
polyester grafts adhered initially, the equivalent figure for ePTFE grafts being 
92.2%. After 1 and 24 hour's in vivo perfusion, 93.8% and 78% respectively of 
initially adhering cells remained attached in the polyester group, corresponding 
figures for the ePTFE grafts being 54.5% and 24.5% respectively. Despite this, 
patency rates were significantly higher in the ePTFE group. On the basis of their 
finding of a greater number of cells attached to occluded, rather than patent 
ePTFE grafts, the authors concluded that, although short term patency appeared 
to be determined by degree, of endothelial coverage in the polyester elastomer 
group, the same did not apply to ePTFE grafts.
Even with the improvement in adherence which occurs with fibronectin 
coating, it is obvious that the seeding process is still highly inefficient when 
considering continuing adherence after restoration of blood flow. Although this 
appears to be less true for polyester elastomer than for ePTFE, the latter is in 
wide clinical use, whereas the former remains in an experimental stage of 
development. There is therefore a need to investigate alternatives to fibronectin.
It is noteworthy that all the above studies have been carried out using cells 
of a species or type other than adult human endothelial cells. The latter cell type 
has always proved more resistant to satisfactory growth in culture than have 
bovine, canine or umbilical vein cell types. It therefore remains to be established 
whether the conclusions made from these studies are also applicable to the adult 
endothelial cell.
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2.7.2 Laminin and Type 4 Collagen
Laminin is another glycoprotein, of molecular weight 800,000 - 1000,000, 
which, in contrast to fibronectin, is found exclusively in basement membranes. Its 
function appears to be an attachment factor for endothelial cells, binding them to 
the equally basement membrane specific type 4 collagen, which makes up the 
connective tissue component of the membrane. It seems that, for all cells which 
normally adhere to a collagenous matrix, there is a specific type of collagen (type
1,2,3 or 4), and a specific protein responsible for binding the cells onto that 
collagen, this specific protein in the case of vascular endothelium being laminin 
(Kleinman 1982). The proposed mechanism is that the attachment protein 
(fibronectin or laminin) initially binds to the substrate (collagen) thereby forming 
a protein-substrate complex onto which cell receptors bind.
Techniques have been developed for isolating basement membrane type 
collagen and laminin from the EHS mouse sarcoma, and both are now 
commercially available (Kleinman et al 1982).
2.7.3 Basement Membrane Gel
A "basement membrane gel" has also been isolated from the same source. 
This contains many of the components of normal vascular basement membrane, 
and has been shown to support the growth in culture of many cell types, namely 
melanocytes, thyroid cells, sertoli cells, hair follicles and retinal pigmented cells 
(Kleinman, personal communication). As the gel has properties of normal 
basement membrane, it may prove to be a suitable substrate for the growth and 
differentiation of endothelial cells within prosthetic grafts.
2.8 Effect of flow on attached cells
Many of the above studies have addressed the question of the newly 
attached endothelial cells' ability to withstand the shear stress of fluid circulating
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through the graft. Methods employed include implantation of seeded grafts into 
living animals (Rosenman et al 1985, Ramalangaona et al 1986), or their insertion 
into specially constructed artificial circulation devices (Sentissi et al 1985, Kesler 
et al 1986). Results have been variable, some studies showing excessive cell loss 
(Rosenman et al 1985) while others were more optimistic (Kesler et al 1986).
More recently, encouraging results were reported from a group in 
California, using human umbilical vein endothelial cells, and seeding these at 
supra-confluent densities onto ePTFE graft segments which had been pre-treated 
with type 1 collagen (Schneider et al 1988). These workers found that, if seeding 
cell density was sufficiently high, then a confluent monolayer was obtainable 
within a period of two hours. By inserting this endothelialised graft into an 
artificial circulation circuit, these workers demonstrated that the monolayer had 
the durability to remain completely intact after perfusion for 1 hour at a flow rate 
of 100 ml/minute. However, if flow rate was increased to 200 ml/minute or 
greater, scanning electron microscopy revealed areas of graft exposure between 
attached cells, although significant proportions of the cells remained attached.
2.9 "Pre-wetting” of grafts
The non wettable and impermeable nature of untreated ePTFE causes 
practical difficulties, in that any cellular attachment will be to the inner surface 
only, with no penetration into the interstices. Drying out of the surface occurs 
very readily, this obviously leading to the death of any cells on its surface. 
Whether permeation into the interstices is necessary is unknown, but it does seem 
probable that cells trapped within the graft substance are more likely to remain 
attached than those adhering tenuously to the surface.
ePTFE can be rendered permeable by brief immersion in alcohol, a 
process which removes the large quantity of air which constitutes the "void space" 
of the material. It has been previously demonstrated that endothelial cells can
52
adhere to ePTFE treated in this way, and then proliferate to confluence (McCall 
et al 1981), although no seeding studies, to date, have used this method of graft 
preparation, most preferring the pre-clot technique.
2.10 Clinical Experience with Endothelial Seeding
Although several animal and in vitro studies have confirmed that 
endothelial seeding is effective as a means of reducing thrombogenicity and 
improving patency rates of small calibre prosthetic vascular grafts, the technique 
has, to date, received little attention in a clinical context. The only clinical studies 
so far reported are those of Herring's group (Herring et al 1984; Herring et al 
1985). These workers seeded 37 Dacron grafts, using a mechanical harvesting 
technique and pre-clot seeding medium. Similar numbers of unseeded grafts 
were implanted for comparison of patency rates. The procedures included extra- 
anatomical bypasses and femoro-popliteal grafts. Results were rather 
inconclusive, there being no significant difference in patency rates between 
seeded and unseeded grafts in the femoro-femoral or femoro-popliteal position, 
although the seeded axillo-femoral grafts did appear to fair rather better than 
their unseeded counterparts. When smokers and non-smokers were considered 
separately, however, there was a significantly better cumulative life patency in 
seeded than unseeded femoro-popliteal grafts in those patients who did not 
smoke. Seeding did, however, seem to have the opposite effect in those patients 
who continued smoking post-operatively.
It is difficult to draw firm conclusions from this study, as numbers were 
relatively small, and patency was judged by clinical means only. More accurate 
follow-up is now possible by means of Digital Subtraction Angiography and 
Indium-lll-oxine labelled platelet scanning.
Herring subsequently reported the occurrence of endothelium within a 
seeded graft which required re-exploration on the 90th post-operative day, due to
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the occurence of a distal embolism of unknown source. Seeding on this occasion 
was carried out with cells obtained enzymatically from a segment of external 
jugular vein. The actual seeding technique used was a modification of the 
standard pre-clot technique. Histological examination of a segment of graft 
removed at embolectomy, taken from a point approximately 10 cm. from the 
distal anastomosis, revealed that a large part of the surface was covered by an 
endothelial like monolayer, with an absence of the usual subendothelial smooth 
muscle cells or fibroblasts.
No other histological examination of seeded human grafts has yet been
made.
2.11 The Mesothelial Cell - an Alternative to Endothelium?
In 1984 a group from the Middlesex Hospital in London, realising that 
mesothelium had many functional, morphological and embryological similarities 
to endothelium, suggested that mesothelial cells may be a suitable alternative as a 
non-thrombogenic lining for prosthetic vascular grafts. On the basis of some 
experiments in which damaged and undamaged segments of rat intestine were 
exposed to blood in a Baumgartner chamber, these workers concluded that an 
intact mesothelial layer had thromboresistant properties similar to those of 
endothelium (Clarke et al 1984).
These workers then developed a means of harvesting mesothelial cells 
from rat omentum by incubating the omentum in collagenase. The cell 
suspension was cultured to confluence and passaged into fresh dishes containing 
Thermanox cover slips. When the cells had attained confluence, the cover slips 
were placed in a Baumgartner chamber and exposed to blood flowing at 160 
ml/min for 10 minutes. On examining the cell monolayer by electron microscopy 
they found a complete absence of adhering platelets, leading to the conclusion
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that mesothelial cells in culture possess the same thromboresistant properties as 
the intact mesothelium used in their previous studies (Nicholson et al 1984).
In a follow-up to this work, the Middlesex group seeded three canine 
abdominal aortic "Vascutek" grafts with omentally derived mesothelial cells, using 
pre-clotting blood as the seeding medium. One control, unseeded graft was 
inserted in a fourth animal for comparison. On examining the graft surfaces by 
scanning electron microscopy after 1 month, they found that all the seeded grafts 
had developed a confluent lining of cells morphologically resembling 
mesothelium. By comparison, the control graft demonstrated no cellular lining 
(Clarke et al 1984). The authors concluded that mesothelial cells may be a 
suitable alternative to endothelial cells for seeding into prosthetic grafts.
In support of this, Bull has recently reported a study which demonstrates in 
dogs that mesothelial seeded Vaskutek grafts produce significantly more 
prostacyclin after implantation, than equivalent unseeded grafts (Bull et al 1988).
CHAPTER 3 
GENERAL OUTLINE AND AIMS OF STUDY
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3.1 Introduction
Before any possible clinical benefit of an endothelialised prosthetic graft 
lining can be evaluated, it is important first of all to ascertain whether or not this 
goal can be achieved with currently available graft materials. It is necessary to 
establish not only that the cells adhere, but that they adhere and spread out 
rapidly, preferably by the time it takes to fashion the anastomoses at either end of 
the graft. Only if this occurs is it likely that any attached cells will be able to resist 
the shear stresses to which they are exposed when blood flow is commenced. The 
formation of a confluent monolayer within this time should, theoretically, be the 
best way to prevent platelet activation within the crucial first hours and days of 
the graft's life.
To date, only one study has been reported which has demonstrated the 
growth to confluence of adult human saphenous vein endothelial cells within 
segments of ePTFE graft material. For this to occur the authors found that a pre­
coating of the grafts was essential - in their case the pre-coating used was a 
combination of commercially available collagen and human fibronectin (Foxall et 
al 1986). No evidence was, however, obtained as to the proportion of seeded cells 
which actually attached to the prosthesis, and only the one substrate preparation 
was evaluated. In addition, a period of 18 hours' incubation was allowed for cell 
attachment. From the point of view of seeding immediately prior to graft 
implantation this is clearly impractical.
As ePTFE is the most widely used prosthetic material for small vessel 
bypass, it is relevant to establish whether the findings described in chapter 2 in 
relation to bovine and human umbilical vein endothelial cells apply also to the 
adult cell. This is of obvious importance if the process is to become clinically 
useful. An immediate seeding technique must be shown to result in attachment 
and spreading of large numbers of cells in as short a time as possible.
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In addition, it is important to establish the likely behaviour of attached 
cells when exposed to the shear stress of blood flowing at rates equivalent to 
those occurring in vivo. An immediate monolayer is valueless if it is washed off 
immediately blood flow is established through the graft.
3.2 Aims of Study
The aim of the present study was, using an in vitro technique, to answer the 
following questions with regard to endothelial cell seeding of ePTFE grafts, with 
specific reference to clinical applicability of the technique:
1. Is mechanical harvesting as effective as enzymatic methods, in obtaining 
sufficient numbers of viable cells to adhere quickly to a prosthetic surface and 
subsequently proliferate to confluence? This is relevant from the point of view of 
ease, and time taken to harvest the cells.
2. Will adult saphenous vein endothelial cells adhere to FIFE graft 
material in sufficient numbers and sufficiently quickly to make the seeding 
procedure useful in a clinical context, and does pre-coating with any of the 
previously mentioned substrates improve the seeding efficiency? Are adherent 
cells capable of rapidly forming a confluent monolayer within the graft lumen?
3. Do mesothelial cells behave similarly to endothelium when used to seed 
prosthetic grafts, and which substrate is best to use with this cell type? Do these 
cells have potential as a substitute for endothelial cells for seeding of grafts?
4. Are attached cells sufficiently adherent to be capable of withstanding 
blood flowing past at flow rates equivalent to those normally pertaining in 
femoro-distal bypass grafts?
All the studies in the present work were performed using cultured cells. 
This ensured a regular supply of healthy endothelial and mesothelial cells. Cells 
in early passages were used in all experiments to reduce the likelihood of 
artefactual results due to prolonged culture.
CHAPTER 4 
MATERIALS AND GENERAL METHODS 
RESULTS OF HARVESTING AND CELL CULTURE TECHNIQUES
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4.1 Materials
All culture procedures were carried out in a class 2 microbiological safety 
cabinet (Medical Air Technology Ltd., Manchester).
Sterile tissue culture polystyrene flasks, multiwell plates, test tubes and 
pipettes were purchased from Sterilin Limited, Middlesex. Balanced salt 
solutions, culture media and trypsinising solution were obtained from Flow 
Laboratories, Rickmansworth, Herts., and endothelial cell growth supplement (15 
mg), human plasma fibronectin (1 mg), gelatin (2%) and collagenase (crude, type 
1) from Sigma Chemical Company Limited, Dorset. Foetal calf serum was 
purchased from Sera-lab, Sussex. Other media supplements were obtained from 
Flow Laboratories. Laminin 1 mg/ml in tris saline, type 4 collagen 0.5 mg/ml in 
0.5N acetic acid, and basement membrane gel were kindly supplied by Dr. H. 
Kleinman, National Institute of Dental Research, Bethesda, Maryland, USA. 
Type 4 collagen was always neutralised with IN sodium hydroxide prior to use.
Endothelial growth supplement was reconstituted with 5 ml Dulbecco's 
phosphate buffered saline and stored at -20°C until use. Substrate proteins, 
enzymes and serum were made into small working aliquots and stored at -20°C. 
Foetal calf serum was batch tested prior to ordering.
ePTFE grafts were kindly supplied by W.L. Gore & Associates, Flagstaff, 
Arizona. Indium-lll-oxine was purchased from Amersham International pic., 
Buckinghamshire.
An Olympus CK inverted microscope with phase contrast was used for 
examination of the cell cultures (Olympus, Tokyo).
4.2 Culture Media
The choice of media was based upon previous reports of successful culture 
of these cell types.
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a. Endothelium
Endothelial cells were grown in Medium 199 with Earle's salts and 20mM 
HEPES buffer. This was supplemented with 20% foetal calf serum, endothelial 
cell growth supplement 25ug/ml, heparin 15 IU/ml, sodium bicarbonate 1.4 g/1, 
L-glutamine 200 mg/ml and Penicillin/Streptomycin solution (5000 IU/ml 
Penicillin and 5000 mg/ml Streptomycin) in a concentration of 1 ml per 100 ml of 
complete medium. The pH of the medium was adjusted to 7.2 - 7.4 by the 
addition of IN HC1 or NaHCC>3 as required. Medium was made up in 500 ml 
quantities and stored at 4°C until use.
All flasks for endothelial cultures were pre-coated with either fibronectin 
or 1% gelatin prior to plating. Pre-coating was achieved by incubating the flask at 
37°C for 1 hour with 1 ml fibronectin or gelatin covering the flask floor. 
Following incubation, excess protein solution was removed, and the remainder 
allowed to dry onto the surface. Before introducing the cell suspension excess 
unbound protein was removed by washing with Dulbecco's phosphate buffered 
saline (DPBS).
Pre-coating was used routinely for culture of endothelium in view of the 
reported difficulties in growing endothelial cells to confluence on uncoated cell 
culture surfaces (Ramalanjaona et al 1986).
b. Mesothelium
Medium used for the mesothelial cultures was Ham F12 with 10% foetal 
calf serum, L-glutamine and Penicillin/Streptomycin, all in the same 
concentrations as for the endothelial medium. Flasks containing mesothelial 
cultures were "gassed” with 5% carbon dioxide in air prior to firm tightening of 
the flask cap.
All primary cultures and subsequent subcultures were grown in 25 cu r  cell 
culture flasks by incubation at 37°C.
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4.3 General Methods
4.3.1 Harvesting Techniques
a. Endothelium 
Enzymatic
For harvesting of macrovascular endothelial and mesothelial cells, 
collagenase was reconstituted immediately prior to use with Dulbecco's 
Phosphate Buffered Saline containing calcium and magnesium (DPBS), such that 
the final collagenase activity was 630 units/ml. Before use, the collagenase 
solution was sterilised by injection through a 0.2 micron syringe filter (Sigma).
Macro-vascular endothelial cells were obtained from segments of adult 
long saphenous vein using the method of Watkins (Watkins et al 1984). Veins 
were received from patients undergoing varicose vein surgery or femoro-distal 
bypass in whom the vein was deemed unsuitable for use as the graft. The vein 
segment was placed, immediately after its removal, in a 50 ml container 
containing 15-20 ml Hanks balanced salt solution, and transferred to the 
laboratory as quickly as possible. Following cannulation with a "Venflon" 
cannula, it was flushed out several times with fresh Hank's balanced salt solution 
(HBSS) to remove red blood cells as much as possible. One end was clamped 
with an artery forceps and the vein filled to distension with collagenase solution. 
The other end was clamped, the vein immersed in 20 ml pre-warmed HBSS in a 
sterile 50 ml container, and incubated in a water bath held at 37°C for 20 
minutes.
Following removal of the clamps and evacuation of the contents into a 10 
ml sterile test tube, the vein was flushed several times with 5 ml serum free 
culture medium E199. The cell suspension was centrifuged at 1000 rpm for 5 
minutes at 4°C, and the supernatant discarded. The cell pellet was resuspended 
in 5 ml serum free medium and centrifuged once more at 1000 rpm for 5 minutes.
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Supernatant was discarded and the pellet resuspended in 5ml complete medium 
warmed to 37°C. A small aliquot of this was taken for cell counting, and the 
remainder of the cell suspension was seeded into a 25 cm^ gelatin- or fibronectin- 
coated culture flask.
After 24 hours the medium was removed and any red cells washed away 
with fresh medium. The cells were re-fed with 5 ml medium. They were then fed 
every 2-3 days until confluent. When colonies became confluent, the volume of 
medium was increased to 8 -10 ml.
Mechanical
Mechanical harvesting of endothelial cells was by the method described by 
Ryan & White (Ryan & White 1985).
The vein segment was opened longitudinally and washed with complete 
medium to remove red cells. The inner surface was gently scraped with a broad - 
bladed disposable scalpel, the material adhering to the blade then being removed 
by immersion in 5 ml of complete medium. The resulting suspension was drawn 
gently up and down into a 10 ml syringe through a 19G needle in an attempt to 
separate cell clusters as much as possible. A small aliquot was withdrawn for 
counting, the remainder being seeded into 25 cm^ flasks as for enzymatically 
harvested cells.
Microvascular endothelium
Microvascular endothelium was harvested from subcutaneous or intra- 
abdominal fat using the technique described by Jarrell (Jarrell et al 1986). 
Portions of fat were minced into small fragments, and incubated in collagenase in 
Dulbecco's phosphate buffered saline, calcium and magnesium free (DPBS 
CMF), for 20 minutes. Collagenase was made up in a solution of 4 mg/ml., with a 
volume to weight ratio of 1 ml/gm of tissue. The minced fat was incubated in the
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collagenase in an Ehrlmeyer flask for 20 minutes at 37°C. Constant agitation was 
effected by the use of a shaking water bath, and a small "spin bar" placed in the 
bottom of the flask. The resultant "slurry" was centrifuged at 1000 rpm for 5 
minutes. All fatty tissue rises to the top during the spinning, leaving a cell pellet 
consisting of endothelial cells and red blood cells, along with any contaminating 
stromal cells which may be present.
The cell pellet was washed twice with DPBS CMF with 1% bovine serum 
albumin (BSA). It was then suspended in 45% Percoll in PBS CMF and 1% BSA, 
which was centrifuged in a fixed angle centrifuge at 13000 rpm at 4°C for 20 
minutes. During this procedure a narrow whitish band, which Jarrel claims to 
consist of individual microvascular endothelial cells, forms at the top of the 
suspension. After centrifugation this band was pipetted off and cultured, using 
the same methods as for macrovascular endothelial cells.
b. Mesothelium
Mesothelial cells were obtained from portions of human omentum from 
patients undergoing laparotomy.
The omentum was placed, immediately after removal, into a 50 ml sterile 
container containing 15 ml HBSS without calcium and magnesium at ambient 
temperatures, and at pH approx. 12-1 A. The specimen was transported to the 
laboratory as quickly as possible, transferred to a container with 10 ml 
collagenase solution maintained at 37°C in a water bath. Following incubation at 
this temperature for 20 minutes, the omentum was removed, the collagenase/cell 
suspension transferred to a 10 ml sterile test tube, and centrifuged at 1000 rpm 
for 5 minutes at 4°C. The collagenase was removed and the cell pellet washed 
twice with complete medium by spinning at 1000 rpm for 5 minutes, at 4°C.
The pellet was finally suspended in 5 ml of medium, and plated in an 
uncoated 25 cm^ tissue culture flask.
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4.3.2 Confirmation of endothelial identity
Endothelial cells were identified by the characteristic epithelial 
morphology, the "cobblestone" appearance of confluent monolayers and the 
presence of factor Vm antigen on the cell surface as revealed by 
immunofluorescent staining. The presence of a positive factor VIII stain is widely 
accepted as confirmatory evidence of an endothelial phenotype (Jaffe et al 1973; 
Wagner & Marder 1984).
Method
Anti-factor VIII immunoperoxidase staining was performed by the 
Department of Pathology, Ninewells Hospital and Medical School. Briefly, 
cultures were fixed in acetone, incubated with rabbit anti-human factor Vm 
antibody followed by fluoroscene-isothiocyanate conjugated goat anti-rabbit 
globulin. The stained cultures were examined by light and transmission electron 
microscopy.
4.3.3 Confirmation of mesothelial identity
Mesothelial cells unfortunately have no characteristic markers, but their 
nature was implied by the presence of an epithelial morphology, monolayer 
formation, and the presence of microvilli on transmission electron microscopy. 
Morphologically, these cells are quite different from endothelial cells. 
Characteristically, mesothelial cells in culture exhibit a varied morphology before 
reaching confluence, with islands of polygonal cells interspersed with stellate and 
spindle shaped ones (Whitaker et al 1982).
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4.3.4 Subculture of cells
When confluent cell coverage extended virtually completely across the 
flask floor, they were resuspended by treatment with a solution of 0.05% (w/v) 
trypsin (1:250) and 0.02% (w/v) EDTA Culture medium was removed from the 
flask and replaced with 1 ml Hank's balanced salt solution without calcium and 
magnesium. This was incubated at 37°C for 1 minute, the HBSS then being 
removed. 1 ml of trypsin/EDTA was added, incubated at 37°C for one minute, 
and excess trypsinising solution removed. Incubation was continued until visible 
separation of the cell monolayer had occurred. This usually took place after 4-5 
minutes.
Medium with serum was added, and the monolayer suspended by gentle 
agitation. The volume of medium added depended on the split ratio required, 5 
ml being allowed for each new flask to be used. Once completely suspended, the 
cell supension was replated into 25 cm^ flasks, the number of flasks depending on 
the split ratio required. A small (0.1 ml) aliquot was saved to obtain a cell count.
In order to compare the growth characteristics of each of the cell types on 
each of the different substrate proteins, a small number of the primary 
endothelial cultures were subcultured onto flasks coated with laminin or type 4 
collagen. Similarly, a small number of primary mesothelial cultures were 
subcultured onto flasks coated with fibronectin, laminin, or type 4 collagen. Pre­
coating with laminin and type 4 collagen was achieved using the same technique 
as for coating with gelatin or fibronectin (see paragraph 4.2).
4.3.5 Cell Counting
Counts of freshly harvested cells were obtained using a Neubauer counting 
chamber. For ease of cell recognition, all aliquots used for counting were diluted 
1 in 3 with crystal violet (0.1%) in citric acid (0.1M) (Paul 1975). This was
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necessary on account of the inevitable presence of red blood cells, even after 
repeated washing of the specimen.
As chamber depth was 0.1 mm, the total counts obtained from five 1 mm^ 
squares in each of the two chambers gave the cell number per mm^ of cell 
suspension. Thus, total harvested cell count in the stained suspension = count in 
2 chambers x 3 x 1000 x initial volume in ml.
Cells being trypsinised for passaging after initial growth to confluence 
were counted in a similar manner, except that crystal violet staining was 
unnecessary.
4.3.6 Estimation of Cell Population Doubling Number 
Population doubling number (PDN) for primary cultures was estimated 
using the formula
PDN = log2 Nf/Ni 
where Nf = cell count at confluence 
Nj = initial cell count 
Doubling number was obtained for subcultures by estimating log2  of the 
split ratio used. For example, a confluent culture trypsinised and replated into 2 
new flasks (1:2 split) will have undergone one (log2  2) population doubling when 
both the new flasks reach confluence. Similarly, a 1:4 split will require cells to 
undergo 2 doublings (log2  4) to reach confluence.
The cumulative population doubling number was obtained by summing the 
individual PDN's in each passage. The population doubling time was obtained 
using the formula PDT = time in days from initial plating until confluence was 
reached/PDN.
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4.3.7. Electron microscopy
Scanning electron microscopy was carried out, using a standard technique, 
by the Department of Pathology, Ninewells Hospital and Medical School. Briefly, 
specimens for scanning electron microscopy were fixed in glutaraldehyde, 
dehydrated in a graded series of acetone, critical point dried and sputter coated 
with gold-palladium. They were then examined in a Jeol J.S.M. 35 scanning 
electron microscope.
4.4 Harvesting Technique - Results
a. Endothelial Cells
Enzvmatic Harvest
Lengths of vein used for the experiments ranged from 1.5-10.0 cm., with an 
average available endothelial surface area of 4.5 _± 2.5 cm? (Table 1).
Cells were harvested enzymatically from 23 saphenous vein segments. 
Average cell yield was 2.6 _+ 1.2 x 10  ^per err? of vein surface. The majority of 
the cells obtained in this way were successfully grown to confluence (see below).
Mechanical harvesting
Mechanical harvesting was used in an attempt to culture endothelial cells 
from 12 saphenous vein segments. Lengths of vein used ranged from 1.5 - 34 cm, 
with an average endothelial surface area of 6_± 10.2 cm?
Cell counting was attempted, but proved difficult for mechanically 
harvested cells, as the cells tended to occur in clumps, and excessive debris made 
cell identification difficult. Coulter counting was also precluded by the 
occurrence of cell clumps. For these reasons, estimated counts were considered 
too inaccurate to be of value.
None of the primary cultures attempted in this way was successful in 
producing a confluent monolayer, the best result being the adherence of one or
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TABLE 1
ENDOTHELIAL CULTURES - YIELD AND TIME TO 
CONFLUENCE
Culture Vein size SA Yield Confluence
(cm) (cm2) (xlO4/cm2) (days)
1. 3.0 x 1.0 3 3.7 25
2. 3.0 x 1.0 3 2.3 28
3. 1.5 x 1.0 1.5 1.3 21
4. 2.0 x 1.4 2.8 2.5 28
5. 2.0 x 1.0 2 2.0 21
6. 3.2 x 0.9 2.9 4.1 21
7. 7.0 x 0.6 4.2 1.4 18
8. 7.0 x 0.6 4.2 1.9 20
9. 3.0 x 1.0 3 5.7 17
10. 4.0 x 1.5 6 4.5 19
11. 2.0 x 1.4 2.8 1.4 21
12. 5.5 x 0.7 3.9 2.3 30
13. 7.0 x 1.0 7 1.4 20
14. 4.3 x 1.0 4.3 2.3 14
15. 10.0x1.0 10 2.2 8
16. 10.0x1.0 10 2.6 21
17. 5.0 x 1.0 5 2.0 28
Mean available surface area = 4.5 _± 2.5 cm2 
Mean yield per cm2 = 2.6 _± 1.2 x 104/cm2 
Success rate = 17/23 (74%)
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two isolated colonies, these rapidly dying after a day or two. Although many cells 
were usually visible in the medium, the majority of these failed to attach, even 
after culture for periods of up to 1 week.
Microvascular harvesting
This technique was used 16 times. In ten the source of cells was 
subcutaneous fat from the leg, while in the remaining 6 omental fat was used. In 
the former, large numbers of cells were visible in the primary isolate, occurring 
both individually and in small clumps. These adhered very rapidly and spread out 
within some hours. Initially, many of the cells were morphologically similar to the 
endothelium harvested enzymatically from vein segments, but within 2-3 days a 
large number of elongated spindly cells resembling fibroblasts became apparent. 
These proliferated rapidly to the detriment of the endothelial cells, eventually 
covering the complete flask floor. These cells did not form a confluent 
monolayer, but overlapped each other, forming multiple superimposed layers. In 
no case was a confluent monolayer of cells achieved.
The microvascular technique also released large numbers of cells from 
omental fat. These cells, although epithelial in morphology, resembled the 
mesothelial cells obtained from omentum when incubated without mincing and 
without Percoll centrifugation (see below). Factor VIII staining was negative in 
these cells and transmission electron microscopy revealed surface microvilli, 
suggesting a mesothelial, rather than an endothelial phenotype.
b. Mesothelial cells
28 specimens of omentum were incubated with collagenase as described. 
Specimen weights ranged from 2.1 Gm - 35 Gm, with a mean of 10.4 _± 8.4 Gm 
(table 2). The average cell yield per gram of tissue ranged from 1.2 to 5.6 x 10 ,^
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TABLE 2
YIELD AND TIME TO CONFLUENCE FOR MESOTHELIAL
CULTURES
Culture No. Wt. Yield Confluence time
(Gm.) (xl0^/cm^) (days)
1. 10.4 1.1 21
2. 10.1 1.4 28
3. 18.9 2.3 18
4. 19.1 1.6 21
5. 12.0 1.6 17
6. 8.7 2.8 9
7. 8.2 1.2 14
8. 6.9 1.1 20
9. 2.1 3.6 13
10. 19.3 4.6 7
11. 4.8 4.7 6
12. 2.6 5.2 8
13. 4.4 5.2 21
14. 3.4 4.8 13
15. 5.1 2.8 28
16. 7.2 3.4 21
17. 35.0 4.2 5
Average Weight = 10.4 J: 8.4Gm. 
Average Yield = 3.0 _± 1.5 x 10  ^cells/Gm
69
with a mean of 3.0 _± 1.5 x 10 .^ Cells occurred mainly in small clumps, adhering 
and spreading within 24 hours.
4.5 Cell culture results
a. Endothelium
All results for endothelium now refer to those cells obtained enzymatically 
from vein segments.
Cells were obtained on each occasion, occurring in small clusters (figure 
1). Without exception the cell clusters adhered within 24 hours, the process of 
attachment and spreading of some clusters beginning within 15-30 minutes. 
Thereafter the cells spread out widely and formed small colonies within 1-2 days 
(Figure 2 & 3). Although. adherence and initial spreading was universal, a 
proportion of the cultures failed to grow to confluence, dying after 3-4 days in 
culture.
17 of the cultures (74%) grew to visual confluence covering the floor of the 
flask within 1-4 weeks (table 1), all of these subsequently being subcultured in 
split ratios of 1:2 up to 1:5. The number of population doublings required to 
reach confluence in each case, assuming adherence of all of the cells, is illustrated 
in tables 3 and 4. It should be noted that the split ratio at passage varied, 
explaining the variation in the ratio of passages to number of doublings. 
Considerable differences were noted between different batches of foetal calf 
serum, and this was always batch tested before ordering a new supply. A 
"learning curve" was also noted, in that a higher proportion of failed cultures 
occurred in the initial attempts. Of the last 9 attempts, the success rate in 
achieving confluence was 100%.
Growth rates in primary culture varied somewhat, with population 
doubling times (PDT) ranging from 2.7-9.5 days (mean 4.7 _± 1.7). After 
subculture, however, doubling times were more constant. Those cultures which
Figure 1. Freshly harvested macrovascular endothelial cell isolate, illustrating 
the cells occurring mainly as small clumps floating in the medium. The multiple 
darker spherical cells are contaminating red cells (original magnification x 100).
Figure 2. Small colony of endothelial cells after 2 days in culture (original 
magnification x 100).
Figure 1
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Figure 3. Low power view of multiple colonies of endothelial cells forming after 
2 days in culture (original magnification x 40).
Figure 4. Confluent culture of macrovascular endothelial cells showing 
"cobblestone appearance" (original magnification x 40).
Figure 3
Figure 4
TABLE3
PDN AND PDT OF PRIMARY ENDOTHELIAL CULTURES
llture Ci
(xlO^)
1. 1.1
2. 0.7
3. 0.2
4. 0.7
5. 0.4
6. 1.2
7. 0.6
8. 0.8
9. 1.7
10. 2.7
11. 0.4
12. 0.9
13. 1.0
14. 1.0
15. 2.2
16. 2.6
17. 1.0
Cc Cc/Ci
(xlO6)
1.6 14.5
1.1 15.7
2.1 105.0
1.7 24.3
1.8 45
2.3 19.2
1.8 30.0
1.3 16.3
1.9 11.2
1.0 3.7
1.1 27.5
1.1 12.2
2.0 20
2.0 20
2.0 9
2.4 10.8
1.0 10
PDN Tc PDT 
(days) (days)
4 25 6
4 28 7
7 21 3
5 28 6
5 21 4
4 21 5
5 18 4
4 20 5
3 17 6
2 19 10
6 21 4
4 30 8
4 20 5
4 14 4
3 8 3
3 21 7
3 28 9
Average population doubling time = 5.4 _+ 1.9 days
Ci = initial total yield
Cc = count at confluence
PDN/T = population doubling number/time
Tc = time to reach confluence
71
TABLE 4
CUMULATIVE PDN FOR ENDOTHELIAL CULTURES
Culture No. No. of Doublings No. of Total
in primary culture Passages Doublings
1 4 1 5
2 5 3 10
3 7 2 10
4 5 1 6
5 5 1 6
6 4 1 5
7 5 1 6
8 5 5 12
9 3 3 9
10 2 1 4
11 6 1 7
12 4 4 8
13 4 1 5
14 4 1 5
15 2 3 8
16 3 2 6
17 3 1 5
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were split in a ratio 1:2 reached confluence in 2-3 days, indicating that this was 
their PDT. Similarly, cultures split 1:4 reached confluence in 3-4 days, again 
indicating a PDT of approximately 2 days. Cell yield at confluence ranged from 1 
x 106 to 2.4 x 10  ^(mean 1.7 _+ 0.5).
The discrepancy between PDTs in primary and subculture may be due to 
a "lag phase" of some days following initial plating, during which the cells do not 
divide, although they do attach and spread. Variability in the duration of this 
from patient to patient may account for the differences in PDTs in primary 
culture. Another possible explanation is that only a small proportion of freshly 
harvested endothelial cells are likely to adhere to the culture flask floor. Using 
the total number of cells harvested as Cj in the calculation of PDN will therefore 
almost certainly give an underestimate of the number of doublings occurring, and 
an overestimate of doubling time. At subculture, since only cells with an ability to 
adhere will have survived thus far, the proportion adhering after replating will 
obviously be higher, and this error much smaller.
The maximum number of cumulative doublings occurring in each culture 
is indicated in table 4. Cells were not maintained longer than 12 doublings, since 
it was considered desirable to use cells in early passages for the seeding 
experiments to avoid possible alterations in cell behaviour ensuing from 
prolonged culture and repeated trypsinisations (Watkins et al 1984). By the time 
cells reached 12 doublings there were many large cells with rather bizarre shapes, 
and the development of confluence was delayed, suggesting impending 
senescence. The majority were therefore used for experiments well before this 
stage was reached.
Two of the initially successful primary endothelial cultures subsequently 
had to be discarded because of contamination with another cell type, of 
fibroblastic morphology. These became evident in the first passage, and at 
second passage outgrew the endothelial cells. The source of these cells was
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presumably the adventitia of the donor vein segment. None of the other 15 
cultures demonstrated such contamination, even after multiple passages.
All confluent cultures demonstrated the typical "cobblestone" morphology 
of endothelial cells (figure 4), and representative samples from each donour 
stained positively for factor Vin antigen (figure 5 & 6). The cobblestone 
morphology was quite distinct from the elongated "spindly" appearance of 
fibroblasts in culture (figure 7 & 8).
b. Mesothelium
Of the 28 attempts, cells were successfully grown from 17 (61%). Two of 
the cultures included as failures grew initially, reaching confluence, but 
succumbed to bacterial or fungal contamination before subculture was possible. 
As with endothelium, a learning curve was observed, the last eight successive 
harvests being successful.
The cells took on a varied morphology when subconfluent (figure 9 & 10), 
many of those occurring individually being of a fibroblastic appearance, while 
those in the centre of colonies were small, polygonal and of a more epithelial 
morphology. When confluence was reached, all cells took on a polygonal 
morphology, the whole having a "cobblestone" appearance similar, but not 
identical to, that of confluent endothelial cultures. The latter cell type, on 
transmission electron microscopy, demonstrated surface microvilli, unlike those 
obtained from the saphenous vein segments (figure 11). Mesothelial cells 
appeared of a similar size, but with more easily perceptible cell boundaries and a 
more polygonal shape than endothelium. There was no contamination with other 
cell types in any of the mesothelial cultures, either in primary culture or 
subsequent passages.
The time taken for primary mesothelial cells to attain confluence ranged 
from 6-28 days. Average population doubling time was 5.8 _± 3 days (table 5).
Figures 5 & 6
Figure 5. Positive immunofluorescent staining for factor VIII antigen in 
cultured macrovascular endothelial cells (original magnification x 100).
Figure 6. Higher power view of factor VUI staining in endothelial cells, 
illustrating multiple granules dispersed over the surface of the cells (original 
magnification x 200).
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Figures 7 & 8
Figure 7. Confluent endothelial culture (original magnification x 100).
Figure 8 Cultured fibroblasts grown from explants of human skin (original 
magnification x 100).
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Figures 9 & 10
Figure 9. Subconfluent culture of mesothelial cells illustrating pleomorphic 
morphology (original magnification x 40).
Figure 10. Higher power view of mesothelial cells in culture (original 
magnification x 100).
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TABLE 5
PDN AND PDT OF PRIMARY MESOTHELIAL CULTURES
llture Ci Cc Cc/Ci PDN Tc PDT
(xlO^) (xlO6) (days) (days)
1. 1.1 1.3 11.8 3 21 7
2. 1.4 1.2 8.6 3 28 9
3. 4.3 2.3 5.3 2 18 9
4. 3.1 1.2 3.9 2 21 10
5. 1.9 1.0 5.3 2 17 8
6. 2.4 2.9 12.1 3 9 3
7. 1.0 1.5 15.0 4 14 3
8. 0.8 1.0 12.5 3 20 6
9. 0.8 1.6 20.0 5 13 3
10. 8.9 3.5 4.0 2 7 3
11. 2.3 2.5 10.8 3 6 2
12. 1.4 2.3 16.4 4 8 2
13. 2.3 0.8 3.5 2 21 10
14. 1.6 1.3 8.1 3 13 4
15. 1.4 1.3 9.3 3 28 9
16. 2.5 2.2 8.8 3 14 4
17. 14.7 2.1 1.4 1 5 5
Average population doubling time = 5.8 _± 3 days
Ci = initial total yield
Cc = count at confluence
PDN/T = population doubling number/time
Tc = time to reach confluence
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TABLE 6
CUMULATIVE PDN FOR MESOTHELIAL CELLS
Culture No. No. of Doublings 
in Primarv Culture
No. of 
Passages
Total
Doublings
1. 3 1 4
2. 3 1 4
3. 2 1 3
4. 2 1 3
5. 2 1 3
6. 3 2 6
7. 4 3 10
8. 3 2 6
9. 5 1 7
10. 2 2 5
11. 3 2 8
12. 4 5 9
13. 2 2 4
14. 3 2 5
15. 3 2 5
16. 3 1 5
17. 1 1 3
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Doubling time in subsequent passages was 3 days, and estimated cell yield at 
confluence ranged from 0.8 - 3.5 x 10  ^(mean 1.8 _+ 0.8 x 10^).
As with endothelial cells, the proliferative life of mesothelium was limited. 
The maximum number of doublings obtained in each of the cultures is shown in 
table 6. A "learning curve" in the initial stages explains the small number of 
doublings achieved in the first 4 cultures. Discemable cell enlargement usually 
occurred after approximately 10 doublings, at which stage cell proliferation 
slowed down. Cells were used in the seeding experiments and adhesion assays at 
as early a stage as possible, usually from 2nd to 6th passage.
4.6 Substrate Variation
Both cell types were successfully subcultured on each of the substrates, 
with the exception of the basement membrane gel. Cells plated onto flasks 
coated with this attached veiy rapidly, but quickly assumed an elongated "stringy" 
morphology. Occasional cells appeared morphologically normal, and seemed to 
begin to form small colonies. The majority, however, remained in the former 
condition, and failed to multiply. The appearance was suggestive of the cells 
"curling up" longitudinally as if to form micro-blood vessels.
There was no difference in the growth capacity or morphology between 
cells plated onto the other substrates, although the process of adhesion and 
spreading did appear rather slower on laminin than on the other substrates.
Attachment and spreading of mesothelial cells to all substrates, and to 
uncoated flasks and wells, appeared slower than endothelium. The former cells 
maintained a rounded up appearance for 1-2 hours, whereas endothelial cells 
seemed well spread by 1 hour (figure 12 & 13). The culture well adherence 
assays confirmed the slower attachment of mesothelium (see below).
Although cell adherence assays for both cell types demonstrated reduced 
attachment to laminin and collagen 4 coated surfaces compared to those coated
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with fibronectin, time taken to reach confluence was the same, whichever 
substrate was used. This suggests that, although laminin and collagen 4 are not so 
"sticky" as fibronectin, those cells which do attach proliferate more quickly. 
Complete confluence was not reached when endothelial cells were plated directly 
onto uncoated culture flasks, although mesothelial cells did proliferate to 
confluence in this situation regularly and rapidly. When endothelium was plated 
onto uncoated flasks, although initial attachment did occur in large numbers, 
detachment of large numbers occurred before confluence was reached.
Figures 12 & 13
Figure 12. First passage endothelial cells, one hour after trypsinisation and 
plating onto fibronectin coated flask. Cells are seen spreading and migrating 
from a large cluster in the lower left comer. The majority of the cells are firmly 
adherent and fully spread (original magnification x 40).
Figure 13. Endothelial culture in first passage 3 hours after plating, showing a 
more wide dispersion of the adherent cells (original magnification x 40).
Figure 12
Figure 13
CHAPTER 5
STUDIES OF CELL ATTACHMENT TO VARIOUS PROTEIN COATINGS
ON CULTURE WELLS
78
5.1 Introduction
For the seeding process to become a practical clinical concept, a time 
interval must be identified which is sufficient to allow firm attachment of 
significant cell numbers, while at the same time enabling the operation to proceed 
relatively unhindered. A series of experiments was therefore performed to assess 
how quickly cells attach to various substrates.
As an indication of the relative abilities of these substrates to enhance 
attachment of cells to the already favourable surface of tissue culture plastic, the 
experiments were carried out first of all using multi-well tissue culture plates. 
Each plate contained 24 wells, 2 cm^ in diameter. For each assay, 4 wells were 
coated with each substrate, and four were left uncoated to act as controls (figure 
14).
5.2 Coating of wells with substrate
Wells were coated with substrate as follows:- 0.5 ml of the substrate 
solution was pipetted into the well. This was agitated gently to ensure complete 
floor coverage. The wells were incubated for 1 hour at 37°C, after which excess 
protein solution was removed. The substrate was allowed to dry onto the plastic 
by further incubation at 37°C. Makarak and Howard (1983) found that drying 
substrate proteins onto tissue culture surfaces in this way resulted in a good 
coating, capable of supporting cell attachment and growth, even in the absence of 
serum. Unbound protein was removed by washing with DPBS. Substrates were 
originally supplied in the following concentrations:-
Fibronectin 0.1 mg/ml
Laminin 1 mg/ml
Collagen 0.5 mg/ml
To obtain a fair comparison, the laminin and collagen were diluted to 0.1 
mg/ml prior to use.
Figure 14. Multiwell plate used for estimating attachment rates to different 
protein substrates. Confluent cells were trypsinised, suspended in complete 
medium and pipetted into the wells at subconfluent densities. At the time 
intervals indicated, overlying medium in each well was removed and the well floor 
washed twice with HBSS. Medium and washings were pooled and a cell count 
performed. After carrying out this procedure for the 120 minute wells, all wells 
were trypsinised and the trypsinised cells counted. Attachment was expressed as 
a percentage of total cells present.
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5.3 Measuring the rate of attachment
The surface area of each well floor was 2 cm^. As cells for each assay 
were taken from one 25 cm^ flask containing, on average, 2 x 10  ^ cells, the 
approximate number of cells seeded into each well was 1.25 x 10~\ giving a 
seeding density of 6.25 x 10  ^per cnA
1 ml of freshly trypsinised cells was pipetted into each well, and the plate 
incubated at 37°C. At 15, 30, 60 and 120 minutes, the overlying medium from 
one well coated with each substrate was removed and the well washed with 
DPBS. The medium and the DPBS were collected and a cell count performed. 
Fresh medium was added to the well, and incubation continued.
Having counted the non-adherent cells up to the 120 minute time period, 
all the wells were trypsinised with 0.25 ml trypsin/EDTA, and the cells in each 
well counted. The proportion of cells adhering in each well was obtained using 
the formula Ca = Ct/(Ct + Cm+W), where Ca represents the proportion of 
initially plated cells adhering, Ct the number of cells released by trypsinisation, 
and Cm+W the number of non-adherent cells in the medium and wash prior to 
trypsinisation.
To improve the accuracy of the cell counts, the cell suspensions from each 
of the washes and trypsinisations were centrifuged for 5 minutes at 1000 rpm and 
resuspended in a very small volume (0.04 ml) of DPBS.
The results enabled a graph to be constructed, illustrating the cell 
adherence rates for the different substrates over a 2 hour period. These studies 
were carried out three times for both endothelial and mesothelial cells, and an 
average obtained.
To avoid any possibility of different media affecting the results, complete 
endothelial medium with 20% foetal calf serum was used in all the attachment 
assays.
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5.4 Statistical analysis of results
The result obtained for each time period was compared, for each substrate 
coating, with that obtained for the equivalent uncoated well. The comparison was 
performed using paired Student's t tests. Each result obtained using endothelial 
cells was compared to the equivalent value using mesothelial cells, again using 
separate Student's t tests.
Differences between the various substrate coated wells were analysed 
using a one way analysis of variance.
5.5 Results
The results together with the statistical analysis of the differences in 
attachment rates between the uncoated and coated culture wells are given in 
figures 15 and 16 and Appendix 1. These studies revealed a significant increase in 
cell attachment to wells coated with fibronectin compared to uncoated wells. 
This applied to both cell types as far as the 60 minute time interval. At 120 
minutes, although endothelial attachment was still better on the fibronectin 
coated wells, the difference was not significant. Attachment rates to type 4 
collagen coated wells were equivalent to those to the uncoated surface 
throughout. Laminin appeared to reduce the rate of attachment, although only in 
the case of endothelial cells at the 60 and 120 minute time intervals, did this reach 
statistical significance. In the case of fibronectin, 86% and 58% of the total 
endothelial and mesothelial cell counts respectively adhered within one hour of 
plating.
The general pattern was for endothelium to attach more rapidly than 
mesothelium. This difference was significant for all time intervals in the case of 
fibronectin coated wells, but only in the later intervals in the case of the other 
substrate coated and uncoated wells.
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Figures 15 and 16 illustrate the attachment curves obtained for the 
different substrates over the 120 minute period. Each point represents the 
average of three experiments. These graphs demonstrate that for all substrates 
other than laminin, the steepest part of the curve is within the first 60 minutes. 
For this reason, in all the subsequent studies 1 hour's incubation was allowed for 
cell attachment. This was considered the optimum time interval, allowing large 
numbers of cells to attach, while also being the maximum time allowable for 
attachment to occur in a clinical context.
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CHAPTER 6
STUDIES OF CELL ATTACHMENT TO UNTREATED AND TREATED
ePTFE GRAFT MATERIAL
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6.1 Methods
Having identified the minimum time period required for reasonable cell 
attachment to ordinary tissue culture plastic, a comparison was now made of cell 
adherence to ePTFE graft material using the same substrate proteins. Standard 
thin-walled 30 micron ePTFE taken from 60 cm by 6 mm ID grafts was used for all 
the experiments.
Two types of experiment were performed
1. Measurement of adherence to small discs of ePTFE immobilised in 
"seeding chambers" fashioned from Eppendorf plastic reaction vials.
2. Measurement of adherence to tubular ePTFE graft segments, using 
indium-1 1 1 -oxine labelling as a measurement of cell attachment.
a. Seeding Chambers
Small cylindrical chambers, 2 cm in length by 1 cm internal diameter, were 
made by cutting off the conical end of 1.5 ml Eppendorf plastic reaction vials 
(Sarstedt Laboratory Wares, West Germany). The cap was removed and re­
applied over a piece of ePTFE just large enough to stretch across the diameter of 
the vial. The cap, when fully closed, held the ePTFE firmly in place, this now 
making up the floor of the chamber (figure 17). In this way, a disc of the material 
1 cm in diameter was immobilised, and available for study.
The ePTFE in the chambers was pre-treated with substrate by incubation 
and drying as described above for the culture wells. Pre-clotted ePTFE was 
obtained from graft segments pre-clotted as described in section 6 .1 .b.
Cells were incubated for 1 hour on each substrate, following which 
overlying medium was removed, the surface washed twice with 0.4 ml DPBS and 
the cells in medium and wash pooled and counted. The attached cells were then 
trypsinised with 0.2 ml trypsene/versene and counted. Percentage adherence was
Figure 17. "Seeding chambers" used for assessing adherence of cells to ePTFE. 
The cap was removed from an Eppendorf plastic reaction vial (a). The conical 
end was removed with a scalpel blade (b). A piece of ePTFE (c) was inserted 
between the cap and the body of the vial (d), the ePTFE thus forming the floor of 
the chamber.
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calculated in the same way as described above for the culture well experiments. 
As the surface area of the ePTFE on the floor of each chamber was small (0.79 
cm^), confluent cells from one flask were used to seed 10 chambers. In this way, 
ten adhesion assays could be performed at one time, the approximate seeding 
density in each chamber being 2 x 10^/10 = 2.0 x 10  ^per chamber (2.53 x 10  ^per 
cm^ of ePTFE). To increase the cell concentration for counting, and thereby 
improve the accuracy of the counts, all cell suspensions from washes and from 
trypsinisation were spun down and suspended in a veiy small volume of medium 
(0.04 ml) prior to counting. The number of cells in ten 1 mm^ squares of the 
counting chamber was always obtained, and this multiplied by 40 to give the count 
in the total 0.04 ml volume (40 mm^).
Some discs were sent for examination by light and scanning electron 
microscopy. Five specimens of each ePTFE preparation (fibronectin coated, 
collagen type 4 coated, laminin coated, pre-clotted, uncoated) were examined 1 
hour after seeding. The five specimens in each substrate group were seeded at 
different cell densities, ranging from 2.53 x 1 0 ^/cm^ to 6.19 x 10^/cm^ to assess 
whether high density seeding may enable the development of a completely 
confluent monolayer on the surface.
b. Graft Segments
6  cm graft segments were coated with substrate using the method 
described by Kesler et al (Kesler et al 1986). The segments were clamped at one 
end, filled with the relevant substrate solution, and clamped at the other end. 
They were then incubated at 37°C for one hour. Excess substrate was allowed to 
drain out, the remainder being allowed to dry onto the graft surface. The interior 
of the graft was washed with culture medium by flushing this through the lumen. 
The grafts were now considered ready for inoculation with cell suspension.
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“Pre-wetting” of Grafts
Cell adherence to ePTFE may be limited by the inherent hydophobicity of 
the surface rather than the actual chemical structure of the polymer. To assess 
whether abolishing this property may improve cell adherence, some ePTFE discs 
and graft segments were pre-treated by immersion in absolute alcohol for one or 
two minutes. Thereafter they were thoroughly washed with serum free culture 
medium to remove the alcohol, before being inoculated in the usual way. McCall 
and colleagues have previously shown that pig aortic endothelial cells will adhere 
to and proliferate on ePTFE treated in this way (McCall et al 1981).
Pre-clotting of grafts
Rather than adding cells to the pre-clot blood before introducing the blood 
into the graft, the following procedure was adopted :
The graft segment was placed in a sterile 13 ml test tube, which was filled 
with 10 ml whole blood. This was left to clot for 2-3 hours.
The graft segment was removed and placed in a sterile test tube containing 
Dulbecco's phosphate buffered saline (DPBS). Blood clot was broken up by 
vigorous shaking of the tube. The graft was washed and rinsed several times with 
fresh DPBS until macroscopically free of red blood clot. This treatment 
facilitated scanning electron microscopy by removing to a large extent the cellular 
elements trapped within the pre-clot matrix.
Following this procedure, cells were seeded into the lumen as for the other 
graft preparations.
Inoculation of Graft Segments
Inoculation was performed by running a recently trypsinised suspension of 
cells into the lumen of the graft segment, one end being occluded with a "bulldog” 
vascular clamp. When the segment was filled, the free end was also clamped, the
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whole then being placed in an incubator at 37°C. Incubation was for a period of 
1 hour. During this time, the segment was turned through 90° at 15 minute 
intervals to ensure an even distribution of cells.
Assessment of cellular attachment to graft segments
Cell adherence was examined quantitatively by indium-lll-oxine labelling, 
and qualitatively by light and scanning electron microscopy.
Sharefkin demonstrated that adult human endothelial cells could be easily 
and rapidly labelled with this isotope, with no discernible effect on the cells' 
subsequent ability to adhere to a prosthetic surface (Sharefkin et al 1983). These 
authors suggested that this may be a reliable way of quantitating cellular 
adherence to prosthetic surfaces.
Cell labelling technique
Radioactivity of all specimens was measured using a well collimated 4 cm 
sodium iodide detector linked to a dual channel spectrometer. The distance 
between detector and specimen was kept constant at 26 cm.
Newly trypsinised cells were suspended in 5 ml serum free medium E199 
and the cell suspension immediately divided into two equal volumes, for seeding 
into two graft segments (approximately 1 x 1 0  ^ cells per graft segment). 5 MBq 
Indium-lll-oxine was added to each supension, which were then incubated for 10 
minutes at 22°C. Activity of the labelled cell suspensions was measured in counts 
per minute.
After centrifugation at 1000 rpm for 5 minutes at 4°C, the supernatant was 
separated from each of the cell pellets, and the pellets resuspended in 1 .1 ml fresh 
medium, containing serum. The activity in the new cell suspensions and the 
supernatant fractions was measured. Labelling efficiency was estimated by 
dividing the activity of the resuspended cell pellet by the total activity present.
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Calculation of cell retention
0 . 1  ml of the freshly suspended and labelled cell suspension was withdrawn 
to estimate spontaneous leakage of activity from the cells. The remainder was 
seeded into the graft segment as described above. Initial total counts were 
measured prior to incubating the graft segment.
Following incubation for 1 hour, contained medium and unattached cells 
were drained, the lumen of the graft gently flushed with culture medium, and 
activity in both graft and washings measured.
To compensate the above results for spontaneous leakage of activity from 
the cells during the period of incubation, the small aliquot (0 . 1  ml) of labelled 
cells removed prior to inoculation of the graft was incubated in a test tube in the 
same incubator as the graft, for the same time interval. Spontaneous leakage was 
estimated by dividing counts in supernatant, after centrifugation at 1000 rpm for 5 
minutes, by the initial counts of the original aliquot. This result was then 
expressed as a percentage leak over the appropriate time interval.
Knowing the rate of leakage from cells into medium, it was possible to 
calculate the total number of counts, at the end of the incubation period, which 
should be attributable to indium contained within cells. After spinning down the 
effluent from the post-incubation specimen, the cellular counts in this were 
measured. This was then subtracted from the total expected post-incubation 
cellular counts, to give an estimate of cellular counts remaining in the graft. This, 
taken as a percentage of the total cellular counts, gave an estimate of the 
percentage of seeded cells remaining attached to the graft segment. Appendix 3 
illustrates the calculations for each experiment.
This experiment was repeated five times for each of the following 
substrates :-
1. Uncoated FIFE
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2. Fibronectin coated PTFE
3. Laminin coated PTFE
4. Collagen type 4 coated PTFE
5. PTFE prepared by "pre-clotting" the graft segment using the method 
described above.
The experiments were carried out using both endothelial and mesothelial
cells.
Preparation of specimens for scanning electron microscopy
Specimens were immersed in liquid nitrogen slush and transferred onto 
specimen holders in liquid nitrogen. Specimen holders were then transferred to 
an Edwards EPDZ tissue dryer at -70°C. The vacuum and temperature were 
maintained overnight in the presence of P2 O5 . Specimens were warmed up to 
30°C and removed from the freezer dryer.
Specimens were fixed on the specimen holders with silver Dag (Agar 
Scientific). Once the dag was dry, specimens were coated with Gold in an 
Edwards S150 sputter coater.
6.2 Statistical Analysis of Results
Differences in one hour attachment rates between uncoated and substrate 
coated ePTFE (including pre-clotted ePTFE) were compared using Student's t 
tests for paired data.
Differences between the various substrate coated specimens were analysed 
using a one way analysis of variance.
6.3 Results - Seeding Chambers
Ten adhesion studies were carried out for each substrate preparation using 
endothelium, and ten using mesothelium. To assess whether abolishing the
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hydrophobicity of the ePTFE may enhance substrate binding and therefore 
improve cell adherence, the experiments were repeated after immersing the 
ePTFE discs in alcohol prior to incubation with substrate. These assays were also 
repeated ten times for each cell type. For comparison, equal numbers of pre- 
clotted and untreated discs were also seeded, and adhesion quantified. The 
percentage attachments obtained are illustrated in figure 18. The actual results, 
together with the data from which these percentages were calculated and the 
statistical analysis thereof, are tabulated in appendix 2 .
a. Endothelial Cells
All substrate coatings greatly improved the one hour cellular attachment 
as compared to the uncoated controls (p< 0.001 in each case). There was, 
however, no significant difference between the different substrates (F = 1.0703, 
one way analysis of variance).
The wide ranges and standard deviations obtained for the matrix protein - 
coated specimens demonstrate a high variability in attachment rates to ePTFE 
coated with these substrates. This was particularly apparent for endothelial cells 
in the case of fibronectin coated graft material. Least variation was observed in 
those ePTFE discs which were pre-clotted prior to seeding.
Pre-treatment of the graft material with absolute alcohol prior to substrate 
coating failed to improve attachment efficiency, although when this treatment was 
applied to uncoated ePTFE, cell retention did improve significantly (p< 0.001) 
(figure 19).
b. Mesothelial Cells
Mesothelial cells attached most readily to fibronectin coated graft 
material, with an average of 54% of cells attaching after 1 hour's incubation 
(figure 18). This was significantly better than the attachment to collagen type 4
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(p< 0 .0 1 ) or laminin (p< 0 .0 0 1 ) coated specimens, although each of these 
conferred a benefit over the uncoated material (p< 0.001). Attachment of 
mesothelial cells to pre-clotted ePTFE was poor, with an average of only 19.9% 
after one hour. This was not significantly different from untreated specimens. 
Pre-treatment of the ePTFE with alcohol did not improve attachment rates of 
mesothelial cells to pre-coated or uncoated graft material (figure 2 0 ).
6.4 Results - Indium Labelling Experiments
Average labelling efficiency for endothelial cells was 37% _± 14%, with a 
range of 14% to 63%, while that for mesothelium was 52% _+ 19%, with a range 
of 13% to 75%. Spontaneous leakage rates of isotope from the endothelial cells 
after 1 hour's incubation at 37°C averaged 38% _+ 15%, while those of 
mesothelial cells averaged 32% jf 13%.
Estimated adherence rates for the different graft preparations were as 
indicated in figure 21. Again, pre-treatment of the graft substantially improved 
uptake of both cell types. Although endothelial attachment was improved by all 
substrate coatings, the result for the laminin coated graft failed to reach statistical 
significance. Fibronectin coating, and mesothelial seeding gave the best seeding 
efficiency. Pre-clot was the graft preparation which gave the least variability in 
results.
There was no difference between the substrates with regard to their ability 
to potentiate endothelial attachment, but for mesothelium, fibronectin was 
significantly better than the others (p< 0 .0 0 1 ), and pre-clot was significantly 
inferior (p< 0 .0 1 ).
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CHAPTER 7
LIGHT AND SCANNING ELECTRON MICROSCOPY STUDIES
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7.1 Light microscopy of seeded ePTFE
All specimens examined by light and scanning electron microscopy had 
been incubated with cells for one hour only.
Ten specimens of each ePTFE preparation (fibronectin, laminin and type 
4 collagen coated, pre-clotted and uncoated) were examined, and the features 
illustrated in the photomicrographs were consistent in all cases. Histological 
examination of pre-treated (pre-coated or pre-clotted) ePTFE seeded with 
endothelial cells revealed the presence of sheets of confluent flattened cells 
adhering to the surface (figure 22 & 23). In some pre-coated graft segments 
sheets of cells extended round as much as 2/3 of the graft circumference, 
although in no case was complete confluence achieved round the whole internal 
surface.
Cells seeded onto untreated ePTFE failed to attach, there being only 
occasional rounded up cells visible on the surface.
Examination of specimens seeded with mesothelial cells demonstrated 
many rounded up, plump-looking cells, with relatively few showing signs of 
flattening and spreading (figure 24).
7.2 Scanning Electron Microscopy of Seeded ePTFE
This examination was carried out on ten specimens coated with each 
protein substrate, ten pre-clotted with whole blood and ten uncoated. The 
features illustrated were typical of each specimen examined.
Scanning electron microscopy of ePTFE incubated with endothelial cell 
suspensions for 1 hour revealed large confluent areas of flattened cells covering a 
large percentage of the surface (figures 25, 26, 27). In areas not covered with 
cells the nodes and fibrils of exposed ePTFE were visible, with numerous rounded 
up cells. High power views enabled visualisation of the attached cells in more 
detail, their nuclear elevations being clearly seen, together with cell junctions and
Figures 22a & 22b
Figure 22a. Light micrograph of ePTFE graft segment pre-treated with type 4 
collagen, seeded with macrovascular endothelial cells, and allowed to incubate 
for 1  hour. Flattened cells are seen lining the graft (original magnification x 40).
Figure 22b. High power view of endothelial cells lining a collagen-coated 
ePTFE graft (original magnification x 100)
Figure 22a
Figure 22b
91
cells actually in the process of spreading (figures 28 to 32). Again, these 
appearances were common to all the substrate preparations and to pre-clotted 
whole blood.
The appearance of "patchy" endothelialisation and large areas of bare 
polymer was seen in the pre-coated grafts irrespective of the cell seeding density, 
whereas cells seeded onto pre-clotted ePTFE in numbers greatly exceeding 
confluent density formed a virtually confluent lining within an hour (figure 35 and 
36).
Specimens seeded with mesothelial cells confirmed the light microscopic 
appearance of many rounded up cells, with only a small number of flattened, fully 
spread cells (figure 33, 34, 37, 38). These appearances were common to all 
substrate graft preparations.
Both cell types, when seeded onto uncoated ePTFE, failed to show 
evidence of flattening or spreading (figure 39).
EiIH ie23 Endothelial cells seeded onto ePTFE which had previously been 
pre-clotted" by immersion in whole blood for 3 hours.
Figure 24. ePTFE graft material pre-treated with collagen and seeded 
with mesothelial cells. After incubation for a period of 1 hour, numerous 
’’plump” cells line the graft lumen, representing cells which remain in a 
rounded up state.
Figure 25. Scanning electron micrograph (SEM) of ePTFE pre-treated 
with fibronectin and incubated with macrovascular endothelial cells for 1 
hour. Large areas of confluent cells are seen attached to the surface of 
the material (Bar = 100 microns).
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Figure 26. SEM of ePTFE graft material pre-treated with type 4 
collagen prior to endothelial cell seeding. Large areas of flattened, 
confluent cells are visualised (bar = 100 microns).
Figure 27. SEM of laminin-treated ePTFE seeded with endothelial cells. 
Multiple confluent areas of endothelial cells are visualised, as in figures 
25 & 26. Rounded up, unattached cells cells lie over the attached cells, 
rather than the exposed fabric (bar = 100 microns).
Figure 28. Fibronectin pre-treated endothelial seeded graft illustrating 
fully spread cells with nuclear elevations and close cell to cell junctions. 
Some areas of exposed ePTFE fabric are seen, along with many rounded 
up cells, and cells in the process of spreading (bar = 100 microns).
mm
Figure 29. Higher power view of endothelial seeded fibronectin pre­
treated graft, showing actively spreading cells along with some fully 
flattened and some completely rounded up ones (bar = 10 microns).
Figure 30. High power view of collagen pre-treated ePTFE, incubated
with endothelial cells for one hour (bar = 10 microns).
Figure 31. ePTFE graft ’’pre-clotted" prior to incubation with cultured 
endothelial cells for 1 hour. A fibrinous network is visualised, with 
numerous cells in various stages of adhesion and spreading, ranging from 
completely rounded up to completely flattened (bar = 10 microns).
Figure 32. Higher power view of pre-clotted endothelial seeded graft
(bar = 10 microns).
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Figure 33. ePTFE pre-treated with fibronectin and incubated with 
mesothelial cells for one hour. Many rounded up ceils are seen, with 
only a few apparent areas of flattened cells (bar = 100 microns).
Figure 34. High power view of mesothelial seeded fibronectin-coated 
graft material. Some flattened and spread cells can be seen, but the 
majority remain in a rounded-up state (bar = 10 microns).
Figure 35. ePTFE pre-clotted and seeded with endothelial cells at very
high density (6.19 x lO^/cm^) and incubated for 1 hour. Virtual
confluence has been reached (bar = 100 microns).
Figure 36 High power view of ePTFE pre-clotted and seeded with 
endothelial cells at high density, illustrating cells at various stages of 
attachment, but covering most of the surface (bar = 10 microns).
Figure 37 ePTFE graft material pre-clotted and seeded with mesothelial 
cells at high density. Some attached and flattened cells are visualised, 
but the majority remain in a rounded up state. Many areas of exposed 
ePTFE are seen (bar = 100 microns).
Figure 38 High power view of ePTFE pre-clotted and seeded with
mesothelial cells (bar = 10 microns).
Figure 39 Uncoated ePTFE seeded with endothelial cells. Only a few
rounded up cells are visualised, with no attempt at flattening or spreading
(bar = 100 microns).
CHAPTER 8 
FLOW STUDIES
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8.1 Introduction
Having confirmed that it is possible to achieve a confluent endothelial 
lining in an ePTFE graft within a very short time, it is important to demonstrate 
whether or not such a monolayer will remain intact, or if the cells are likely to be 
washed away immediately blood flow is established through the graft.
In order to answer this question, a series of experiments was performed 
using the best seeding technique as established earlier, implanting seeded graft 
segments into an artificial circulation device, designed to simulate as closely as 
possible the conditions likely to be encountered by such a graft in vivo. Cells were 
pre-labelled with indium-lll-oxine prior to seeding, the amount of radioactivity 
retained after flow enabling the durability of attached cells to be established.
8.2 Artificial circulation circuit
a. Design
The basic design of the circuit is illustrated diagrammatically in figure 40, 
and the actual system is shown in figure 41.
Each end of a 6 cm length of ePTFE graft material (previously seeded with 
labelled cells) was tied to a length of 6 mm internal diameter plastic tubing, 
through which culture medium was circulated by a roller pump (Watson Marlow 
Limited, Falmouth, Cornwall) providing variable rates of pulsatile flow. Any cells 
which detatched were prevented from recirculating by incorporating a membrane 
filter into the circuit (Sartorius Membranfilter GmBh Gottingen, FDR) and the 
temperature of the circulating medium was maintained at 37°C by passage 
through a water bath.
Any air bubbles within the system were removed by a "bubble trap", 
consisting of a partially filled glass cylinder through which the medium circulated. 
An air-filled syringe inserted to the top of the "bubble trap" enabled fine 
adjustments of the pressure within the system. A manometer graduated in mm of
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water was attached to the lower part of the bubble trap. The pressure during the 
experiments was kept constant at 15-20 mm water.
Radio-active counts within the graft segment were measured continuously 
by a probe connected to a counter ratemeter (J & P Engineering, Reading, 
England). Probe-graft distance was kept constant during each experiment.
The system was "primed" with approximately 300 ml of medium containing 
20% foetal calf serum, L-glutamine and Penicillin/Streptomycin, in the same 
concentrations as in the medium used for culturing the cells. The system was 
filled by the use of two Y-connectors as illustrated in the diagram (figure 40). 
With the free ends open and submerged in medium, operation of the pump 
resulted in medium being drawn into the circuit. Once full, the free ends were 
clamped, producing a closed system. The circuit was run for a period of 1 hour 
before placement of the seeded graft, in order to allow the temperature of the 
circulating medium to reach 37°C. During this "warming up time" a segment of 
ordinary unseeded ePTFE replaced the experimental seeded grafts.
For the actual flow experiments, culture medium was used in preference to 
whole blood, in order to facilitate microscopic examination of the graft after flow.
b. Estimation of flow rates
Before carrying out the experiments, the system was callibrated to 
correlate different pump settings with the corresponding flow rates. This was 
done by disconnecting the distal end of the graft segment, and allowing the 
medium passing through the graft to drain into a measuring cylinder. By 
measuring the volume collected over a period of 1 minute, the rate of flow 
through the graft was obtained in ml/minute. For the experiments, pump settings 
correlating with flow rates of 25,100 and 200 ml/minute were selected.
DIAGRAM  O F  A RTIFICIA L CIRCULATION
w a te r bath f ilte r
m an o m ete r
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Figure 40 Diagram of the artificial circulation used for flow experiments.
Figure 41 Photograph of artificial circulation circuit.
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c. Labelling of cells and seeding of grafts
Cells were labelled with indium- 111-oxine as described earlier (see section
6.1). In order to simplify the calculation of cell retention, the problem of 
spontaneous leakage of isotope from the cells was minimised by holding the newly 
labelled cells in suspension at 37°C for a period of 60 minutes. After this time, 
the cells were centrifuged at 1000 rpm for 5 minutes and resuspended in fresh 
medium prior to seeding. Since most leakage occurs within the first 60 minutes or 
so of labelling (Sharefkin et al 1984), this procedure allowed spontaneous leakage 
to be disregarded in the subsequent calculations.
Since pre-clotting of grafts and seeding with macrovascular endothelial 
cells gave the most satisfactory results for the experiments performed under static 
conditions, these methods were used for the flow experiments. Pre-clotting and 
inoculation of the graft segments were achieved using techniques identical to 
those described in section 6.1. In all cases, cells were seeded at supra-confluent 
densities. Following incubation of the cells in the graft for a period of 90 minutes, 
the graft segment was tied into the artificial circulation device as quickly as 
possible. 90 minutes, rather than 60 minutes, was chosen as the incubation time 
in order to maximise initial cell attachment.
d. Calculation of cell retention
Initial radioactive counts were measured immediately after placing the 
graft segment in the circuit (count 0^), and immediately after medium began 
circulating through the segment (count O2 ). Count 0  ^was taken as 100% in each 
case. The difference between 0-^  and O2  was an indication of the initial cell 
detachment on commencement of flow through the graft.
Counts were taken every 5 minutes thereafter for a period of 1 hour. Each 
reading was converted to a percentage of the original count (0-j).
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e. Calculation of shear stress
The shear stress applying under the various flow conditions was calculated 
using the formula:
shear stress = 4Q‘>^ f7(ri)^  
where Q = flow in ml/second
ri = internal radius in cm
^  = viscosity of medium in poise 
The viscosity of the culture medium used was obtained using an Ozwaltz 
viscometer, giving a value of 0.0108 poise.
f. Morphological examination of cells after flow
The morphological appearance of attached cells after exposure to the 
various rates of flow was examined by light microscopy and scanning electron 
microscopy. Representative sections were taken from both ends, and from the 
centre portion of each graft.
8.3 Results
Six experiments were carried out for each flow rate, giving shear stress 
values of 0.21, 0.84 and 1.68 dynes/cm ^ for flow rates of 25, 100 and 200 ml/ 
minute respectively.
The cell number used in each of the eighteen experiments, together with 
the labelling efficiency and the initial cell attachment achieved, is illustrated in 
appendix 4. The mean (+ SD) initial percentage cell attachment was 72.6 _± 8.7.
Average cell retention during one hour at these flow rates is shown in 
figure 42, and the actual results obtained are tabulated in appendix 4. Average 
retention after one hour's flow was 85.7 _± 7.2 at 25 ml/minute, 82.9_± 8.5 at 100 
ml/minute and 79.6 j t  8.9 at 200 ml/minute.
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Figure 42 Results of flow studies. Cell retention at the various time intervals is 
expressed as a percentage of the cells attached before commencement of flow 
(i.e. at time Oj).
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Light and scanning electron microscopy of post-flow specimens revealed 
persistence of the virtually confluent monolayer over the majority of the graft 
surface, even at the highest rate of flow (figure 43, 44), although in those grafts 
exposed to flow rates of 200 ml/minute some "gaps" in the monolayer are 
beginning to appear (figure 45).
Figure 43 Light micrograph of pre-clotted ePTFE graft segment, seeded with 
endothelial cells and subjected to flow at 25 ml/minute for 1 hour. An intact 
endothelial lining is visualised (original magnification x 40).
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Figure 44 SEM appearance of cell monolayer after flow at 100 ml/minute for 1 
hour. The monolayer remains virtually intact.
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Figure 45 SEM appearance of endothelial monolayer after flow at 200 
ml/minute. Gaps are beginning to appear between attached cells, but the 
majority of the surface is still covered by cells which remain fully spread, 
indicating strong attachment.
CHAPTER 9 
DISCUSSION
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9.1 Harvesting techniques
If cell seeding of vascular grafts is ever to become clinically useful, then 
the technique of harvesting must be reliable and easy, and must be performed 
rapidly by personnel with no special expertise in cell biology. It was therefore 
considered relevant to investigate which of the currently available techniques best 
fitted these requirements.
a. Mechanical harvesting
Mechanical harvesting of adult human saphenous vein endothelial cells 
theoretically met these criteria best, and was therefore investigated first. 
Unfortunately, the technique consistently failed to release cells capable of 
growing in culture. Although large numbers of cells were released, the majority 
were non-viable, or unable to attach to the culture surface. The most likely 
explanation for the failure of the technique is that mechanical scraping is 
excessively traumatic to cells, and also removes basement membrane along with 
the endothelium. As cells already attached to basement membrane will have no 
stimulus to attach to another surface, such cells will fail to adhere to culture flasks 
or prosthetic grafts. This technique can therefore not be recommended as a 
means of obtaining cells for seeding of prosthetic vascular grafts.
The reason for the discrepency between these results and those of Ryan 
and White is unclear, but may lie in the fact that, in the latter study, considerably 
longer lengths of vein were available as an endothelial source. These authors did 
not state the average length of vein used, nor did they comment on the cell yields 
obtained (Ryan & White 1986). They were, however, using long saphenous veins 
removed by stripping, and it seems likely that the lengths were substantial.
98
b. Enzymatic harvesting of macrovascular endothelium and omental 
mesothelium
The enzymatic technique for deriving macrovascular endothelium and 
omental mesothelium is reliable, although inefficient. As the total number of 
endothelial cells available per cm^ of vein lumen is 10 ,^ the average cell yield of 
2.6 _+ 1.2 x 104 implies a harvesting efficiency in the order of 26%. This agrees 
with the experience of most authors. It may be that purification of collagenase, or 
substitution with an alternative enzyme, will result in better cell yields.
Despite the inefficiency, large numbers of viable cells are obtained, which 
are capable of attaching rapidly to a suitable synthetic surface and going on to 
proliferate to confluence. Although the overall success rate in these studies was 
only 73%, if the initial "learning curve" is excluded, the success rate was 100% for 
the last 8 attempts. Similarly with omental mesothelial cells, enzymatic derivation 
was consistently successful after an initial learning phase.
This technique proved relatively quick to perform, the complete procedure 
taking approximately 30-45 minutes (20 minutes incubation with enzyme, 10-15 
minutes centrifugation).
c. Enzvmatic harvesting of microvascular endothelial cells
The enzymatic technique described by Jarrell for deriving microvascular 
endothelium from various fat sources has proved disappointing in the present 
studies. Although large numbers of endothelial-like cells occur in the initial 
isolate, the subsequent growth pattern suggests overgrowth with contaminant cells 
in the case of subcutaneous fat, and mesothelial cells in the case of omentally 
derived fat. In addition, the process proved time consuming. An average time 
course for the technique as described would be :- 10-15 minutes for mincing and 
weighing of specimen and making up collagenase in appropriate concentration; 
20 minutes for incubation with collagenase; 20-30 minutes for washes and
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separation of adipose tissue; another 20 minutes for high speed centrifugation in 
Percoll; and 10-15 minutes for further washes. The time in total amounts to some 
80-100 minutes. Omitting the Percoll stage would save perhaps 30-45 minutes, 
but, even then, 50-65 minutes are required.
The concept of harvesting endothelial cells from subcutaneous fat is 
attractive. If, however, it is demanding on time, materials and equipment, as 
found in the present study, then its clinical applicability is limited.
d. Harvesting techniques - conclusion
These results indicate that the simplest, fastest and most reliable technique 
for deriving endothelial cells for seeding purposes is enzymatic derivation of 
macrovascular endothelium from saphenous vein. The method does not require 
previous experience in cell culture techniques, and could be easily performed in 
the operating room.
9.2 Adhesion and growth patterns on the various substrates.
With the exception of basement membrane gel, the substrates tested were 
all equally capable of supporting growth of both endothelial and mesothelial cells. 
One important difference, however, was that endothelial cells failed to proliferate 
to confluence in the absence of some form of pre-coating of the flask floor, be it 
gelatin, or one of the extracellular matrix proteins. Although endothelial cells 
attached rapidly when plated into uncoated culture flasks, subsequent separation 
of the cells occurred, precluding their growth to confluence. Mesothelium, on the 
other hand, regularly proliferated to confluence through multiple passages in the 
absence of any pre-treatment of the culture surface. In addition, mesothelial cells 
thrived in the absence of any specific growth supplements, while endothelium 
required endothelial cell growth factor and heparin. Omission of either of these 
resulted in a marked retardation of endothelial cell growth.
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Under the correct conditions, however, both of these cell types proved 
capable of multiplying to cover many times their original area. For example, cells 
harvested enzymatically from a 2 cm length of vein undergoing 10 population 
doublings will cover 410 cm^, assuming a harvesting efficiency of 20%. This is 
more than adequate to cover a 60 cm x 6 mm ID vascular graft.
The time course (culture well) adhesion studies have indicated that the 
majority of cells, when seeded onto a suitable prosthetic surface at subconfluent 
densities, attach to the surface within 60 minutes of seeding. This is of 
importance when considering the feasibility of immediate seeding in the 
operating theatre context, where the time allowable for cell attachment is limited. 
On the basis of these results one hour was accepted as the optimum practical time 
to allow for attachment to ePTFE graft material in the subsequent experiments.
With regard to the relative adherence of the two cell types to substrate 
coated wells, endothelium attached more rapidly to all the substrates (figures 14 
& 15. Appendix 1).
The attachment studies performed on ePTFE have demonstrated that the 
limited one hour attachment which occurs to the untreated material can be 
improved by pre-treatment with any of the extracellular matrix proteins, or, in the 
case of endothelium, by pre-clotting with whole blood. The average attachment 
rates indicate that the matrix proteins are marginally better in this respect, 
although the range and standard deviations demonstrate a wider variation in 
attachment rates to ePTFE when it is protein coated than when pre-clotted with 
whole blood. SEMs of pre-clotted endothelial cell seeded grafts demonstrated 
cells in various stages of attachment, while cells attached to matrix protein-coated 
grafts were in a more advanced stage of spreading. This suggests that cells attach 
and spread more quickly on the protein coated than the pre-clotted surface.
However, the variability of endothelial attachment to matrix protein- 
coated graft material suggests an inconsistency in the amount of protein binding
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to the ePTFE. This conclusion is supported by the following 1. endothelial 
attachment to pre-clotted ePTFE was more consistent than to matrix protein- 
coated ePTFE, 2. scanning electron microscopy revealed large "gaps" of exposed 
ePTFE between the areas of confluent cells on matrix protein-coated material, 
these presumably representing areas of ePTFE devoid of protein coating, and 3. 
the one hour attachment rates to pre-coated ePTFE were lower than those to pre­
coated tissue culture polystyrene. It is worthy of note that the rounded up, non 
adherent cells present on protein-coated ePTFE lie over the areas of cellular 
coverage, those areas of exposed graft material being devoid of cells. This 
suggests that these areas may be actively hostile to cell attachment.
It is most likely that these gaps exist because protein binding is "patchy", 
and the ePTFE at these points is not covered with protein substrate. Pre-clotted 
grafts, on the other hand, have a more consistent and even dispersal of fibrin 
across the surface. Thus, although the speed of attachment to and spreading 
upon the fibrin pre-clot is slower than to the purified protein coatings, the more 
complete covering of fibrin pre-clot compensates for this.
Although Ramalanjaona demonstrated that fibronectin has the ability to 
form a strong bond with ePTFE (Ramalanjaona et al 1986), the evenness of the 
dispersion of the protein across the surface of the material has not been 
examined. The present studies indicate that protein coverage is variable and 
patchy.
A potential problem with fibronectin coating as a means of promoting 
attachment is that coated grafts exhibit increased thrombogenicity until cell 
coverage is complete. The proponents of fibronectin coating do, however, claim 
that the increased thrombogenicity can be negated by treatment with anti-platelet 
agents (Ramalangaona et al 1986).
Pre-treatment of ePTFE with alcohol does improve endothelial cell 
adhesion rates, although to a lesser extent than substrate coating or pre-clotting.
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Alcohol treatment prior to substrate coating does not produce any apparent 
improvement in cell attachment.
There was a significant trend for endothelial adherence to polystyrene to 
exceed that of mesothelium. Attachment to fibronectin coated ePTFE, on the 
other hand, was more rapid in the case of mesothelial cells. Cell attachment, 
however, is not the only requisite for successful cell seeding of vascular grafts. 
The morphology of the adherent cells is also of importance - large numbers of 
rounded up cells adhering lightly to the surface are unlikely to be as able to 
withstand the shear stress of blood flowing past at arterial pressures as flattened 
out confluent or near confluent cells. Similarly, cells which remain rounded up 
are unlikely to be functionally normal, even if they do remain attached in the 
presence of blood flow. Scanning electron microscopy has revealed that, although 
mesothelial attachment to the fibronectin coated polymer is quantitatively better 
than that for endothelium, attached cells of the latter type are more spread out, 
are therefore more likely to be able to resist shear stress, and are more likely to 
have retained normal functional potential.
The maximum one hour endothelial attachment achieved with any of the 
preparations of ePTFE was 50%. This being the case, cells would require to be 
inoculated at approximately twice confluent density (10^ cells per cm^) in order 
to attain confluence after one hour’s incubation. For a graft 60 cm by 6 mm ID 
(surface area 113 cm^) this would require 113 x 2 x 10  ^ = 2.26 x 10  ^cells. The 
only practical ways of obtaining such large cell numbers for immediate seeding 
purposes are by culturing macrovascular cells, or by Jarrell's technique, using 
microvascular endothelium. The problems with the latter technique have already 
been discussed. Pre-culture of macrovascular endothelium is feasible, although 
not without difficulties. The expertise and facilities necessary for long term 
endothelial culture are not universal, and are expensive. Pre-culture requires a 
period of some weeks, which is often unacceptable in the patients who are most in
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need of an improved vascular prosthesis. Pre-culturing also introduces a potential 
source of infection. In addition, Jarrell has observed chromosomal abnormalities 
in cultured endothelial cells, raising questions as to the advisability of introducing 
these into human subjects (Jarrell et al 1986). It would seem, therefore, that 
further development of the microvascular harvesting technique is the avenue 
most likely to solve the problem of obtaining the high cell numbers required.
One other alternative is to use mesothelium, which is available in very 
large amounts in the peritoneal cavity. The present studies have shown that this 
cell type is capable of adhering to the treated ePTFE surface in numbers 
equivalent to, if not better than macrovascular endothelium, although the 
electron micrographs have shown that the number of fully spread cells is low at 
one hour.
Although an immediate confluent covering is obviously desirable, many 
workers feel that this may not be strictly necessary, the firm adherence of only a 
small number of cells being required. The minimum density of adherent 
endothelial cells required to proliferate to confluence in an implanted prosthetic 
graft is unknown, although Stanley claims to have achieved this in dogs with a 
seeding density of only 8000 cells per cm^ (Stanley et al 1985). At this density, 
however, a period of some weeks is essential to allow the small number of cells 
present to reach confluence, an achievement which requires a veiy high number 
of population doublings. The long term effect of multiple doublings on cell 
function is unknown, but Williams and colleagues are concerned that genetic 
damage may ensue (Williams et al 1987). It is advisable, therefore, to strive to 
cover as much of the graft surface as possible with attached cells, in order that 
excessive proliferation does not occur.
If as much of the surface can be covered with flattened cells as has been 
demonstrated on the present SEM studies, then sufficient cells may be present to 
reach confluence very rapidly, and with a small number of population doublings.
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It is known that endothelial cells in culture secrete many of the components of 
vascular basement membrane (Schor et al 1984; Kramer et al 1984), and it may 
be that if adequate numbers of cells can be encouraged to attach in the first 
instance, then these will produce sufficient extracellular matrix protein to 
stimulate subsequent growth, migration and continuing adherence within the graft 
lumen.
The scanning electron microscopy studies have demonstrated that a large 
proportion of the surface of ePTFE can be covered by large "islands" of confluent 
flattened cells. Cells of this morphology when visualised in tissue culture flasks 
are attached firmly, and are resistant to disruption by flushing fluid over the 
surface. In addition, all the scanning electron micrographs were taken after the 
ePTFE surface had been washed by directing a stream of DPBS forcibly onto the 
material. All the cells visualised had therefore resisted a certain amount of shear 
stress, although this was admittedly brief and uncontrolled. The appearance of 
the cells, does nevertheless suggest that they will be capable of resisting the shear 
stress of flowing blood. Jarrell, after a series of experiments examining the 
strength of attachment of microvascular endothelial cells to plasma coated 
Dacron, concluded that "once cell-to-surface interaction and attachment have 
taken place, the endothelial cells are very firmly adherent".
The indium labelling experiments confirmed the pattern of adherence 
found in the other adhesion assays, with an improved cell attachment to those 
graft segments which were pre-treated with protein, or pre-clotted. The pattern 
of attachment to pre-treated ePTFE immobilised and stretched in a small seeding 
chamber therefore also applies to tubular grafts.
The results of the indium labelling experiments, taken in conjunction with 
the SEM appearances, demonstrate a limitation of isotope labelling techniques as 
an indicator of cell attachment to a prosthetic surface. Although quantitative 
information is obtained as to how many cells are adhering, the state of adherent
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cells remains unknown, i.e. whether they are rounded up or spread out. Only 
microscopic examination can provide this information.
9.3 Flow Studies
The higher initial cell attachment rates in these experiments indicates a 
benefit in incubating the cells on the graft for 90 minutes, rather than for 60 
minutes as in the earlier experiments. This may, however, be considered less 
practical in a clinical context.
The flow studies have clearly shown that endothelial cells which have 
attached to pre-clotted ePTFE over a 90 minute incubation period, have the 
ability to resist detachment when exposed to a shear stress of similar magnitude 
to that experienced in a small diameter vascular graft in vivo.
Average flow rates encountered in femoro-distal bypass grafts are 
commonly stated to be in the order of 100-200 ml/minute (Bernhardt et al 1971; 
Mannick & Jackson 1966, Wilson & McCormick 1988). Although the viscosity of 
blood is higher than that of the culture medium used in the experiments, the 
resulting difference in shear stress is small.
At each of the flow rates tested (25, 100 and 200 ml/minute) there was an 
initial loss of cells immediately flow commenced. However, over the following 60 
minutes, when extensive cell detachment may have been anticipated, the actual 
cell loss was small, even at the highest flow rate. Scanning electron microscopy 
confirms that the pre-flow confluent monolayer remains largely intact after 1 
hour's flow at the lower flow rates (fig. 44), although at rates of 200 ml/minute, 
gaps in the monolayer are beginning to appear (fig. 45).
It may be argued that cell detachment may progress after the first hour. It 
is probable, however, that the maximum cell loss will occur within the first few 
minutes of the cells' exposure to shear stress. Since the loss over this time is 
small, it is unlikely to be of significance thereafter.
CHAPTER 10
CONCLUSIONS AND SUGGESTIONS FOR FURTHER WORK
106
10.1 Conclusions from individual studies.
These studies demonstrate the following:-
1. Enzymatic harvesting of macrovascular endothelial cells from 
autogenous vein is at present the easiest and most satisfactory technique for 
harvesting viable endothelial cells.
2. Enzymatic treatment of omentum consistently releases large numbers 
of viable mesothelial cells.
3. Enzymatic harvesting of microvascular endothelial cells releases large 
numbers of viable endothelial cells, but also many contaminating cells.
4. Under optimal conditions the growth characteristics of endothelial and 
mesothelial cells are similar, both proliferating rapidly to form a confluent 
monolayer of epithelioid cells covering a surface area many times that of the 
original tissue. Mesothelial cells are the less fastidious of the two, requiring only 
the addition of 10% foetal calf serum to grow in culture. Endothelium will only 
thrive in culture if endothelial cell growth factor and heparin are added to the 
medium.
5. Endothelial cells adhere to and spread more rapidly upon tissue culture 
polystyrene than mesothelial cells, whether the surface is coated with extracellular 
matrix protein or not. For continued growth, however, endothelial cells require a 
protein coating on the culture surface, whereas mesothelial cells do not.
6. Although endothelial cell attachment to untreated ePTFE is low, pre­
coating with extracellular matrix protein and pre-clotting with whole blood both 
result in significant improvement. When seeded at supra-confluent densities, 
virtual confluence can be achieved on pre-clotted ePTFE within one hour of 
seeding, although confluence at this time period does not occur on ePTFE coated 
with extra-cellular matrix protein, irrespective of seeding density used. It is 
implied, therefore, that matrix protein binding to ePTFE is patchy and irregular.
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7. Attachment of mesothelium to fibronectin coated ePTFE is 
quantitatively better than that of endothelium. Qualitatively, however, 
mesothelial attachment after one hour is less advanced, with very few of the 
attached cells having spread to their full extent.
8. Although indium-lll-oxine labelling of cells is a reliable way of 
estimating the number of cells attaching to an artificial surface, it provides no 
information as to the condition of the attached cells.
9. Once endothelial cells have formed a confluent monolayer within an 
ePTFE graft, the cells are attached firmly, and are able to withstand the shear 
stress likely to be encountered when such a graft is implanted in vivo.
The optimum seeding technique for clinical use at the present time is 
therefore enzymatic derivation of large vessel autologous endothelial cells, with a 
pre-clot preparation of the ePTFE graft prior to introduction of the cell 
suspension, rather than mixing the cells with the pre-clot blood described in the 
original seeding trials (Herring et al 1978). This latter technique clearly results in 
cell loss when excess clot is evacuated.
The present studies have demonstrated that a period of only one hour is 
sufficient to result in extensive coverage with areas of confluent flattened cells.
Mesothelial cells may be used as an alternative in procedures in which the 
abdominal cavity is opened, but the early degree of graft coverage will be less.
10.2 Overall conclusion and suggestions for future work
The work described in this thesis has shown that an endothelial cell lining 
within an ePTFE vascular graft is a practical proposition. Such a lining can be 
achieved simply, without special facilities, and without the need for time- 
consuming procedures or expensive modification of the graft surface. ePTFE pre­
clotted with whole blood is a suitable surface for rapid endothelial attachment
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and spreading, and may form a confluent monolayer within 1 hour if cell density is 
sufficiently high.
Once endothelial cells are attached and spread upon the graft surface, 
early detachment by fluid shear stress does not occur to a significant extent under 
the conditions encountered in vivo.
Future studies should address the problem of improving cell yield, possibly 
by refining the microvascular endothelial harvesting technique of Jarrel and 
Williams such that purer endothelial populations are obtained. The question of 
the more long term durability of adult human cells attached to prosthetic graft 
surfaces should also be explored in vitro.
A clinical trial utilising the above methods would then be necessary, to 
establish whether attached cells will withstand prolonged shear stress in vivo, 
forming a durable functioning endothelial monolayer, and whether or not this will 
improve the poor long term patency rates of ePTFE grafts.
APPENDICES
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APPENDIX 1
Time Course for Adhesion of Endothelial Cells to Uncoated 
and Substrate Coated Culture Wells over 120 Minutes
Coating
Time
Fibronectin Collagen Laminin Uncoated
15 47 (1.7) 11 (4.0) 4 (1.7) 4 (0.6)
30 56 (1.7) 21 (2.3) 11 (1.2) 18 (2.3)
60 86 (1.2) 54 (1.7) 26(4.0) 48 (3.5)
120 86 (4.0) 73 (1.7) 49 (1.7) 74 (2.9)
Each value represents the mean and standard error of the mean of 3 separate 
experiments, using cells from different donors. Figures are percentages of the 
total number of seeded cells which remain adherent at the different time 
intervals.
Time Course for Adhesion of Mesothelial Cells to Uncoated 
and Substrate Coated Culture Wells over 120 Minutes
Coating
Time
Fibronectin Collagen Laminin Uncoated
15 29 (2.3) 6(1.7) 4 (0.6) 3 (0.8)
30 40 (3.5) 16 (1.7) 10 (3.5) 13 (0.6)
60 58(3.5) 38 (3.5) 18 (3.5) 30 (3.5)
120 72 (2.9) 59 (2.3) 32 (1.7) 51 (6.9)
Each value represents the mean and standard error of the mean of 3 separate 
experiments, using cells from different donors. Figures are percentages of the 
total number of seeded cells which remain adherent at the different time 
intervals.
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T values for differences in attachment rates between uncoated and substrate 
coated wells
a. Endothelium
Fibronectin Collagen Laminin
15 minutes 23.552 1.7146 0
(p< 0.001) NS NS
30 minutes 13.164 0.91856 2.7111
(p< 0.001) NS NS
60 minutes 10.407 1.5492 4.1331
(p< 0.001) NS (p<0.05)
120 minutes 2.4162 0.29704 7.4261
NS NS (p<0.01)
b. Mesothelium
Fibronectin Collagen Laminin
15 minutes 9.0067 1.2247 0.54772
(p< 0.001) NS NS
30 minutes 7.6882 1.6432 0.85424
(p<0.01) NS NS
60 minutes 5.7155 1.6330 2.4495
(p<0.01) NS NS
120 minutes 2.7979 1.0954 2.6605
(p<0.05) NS NS
I l l
T values for comparison of endothelial and mesothelial attachment to uncoated 
and substrate coated culture wells
Fibronectin Collagen Laminin Uncoated
15 minutes 6.2354 1.1371 0 0.54772
(p<0.01) NS NS NS
30 minutes 4.1312 1.7321 0.27386 2.1004
(p<0.05) NS NS NS
60 minutes 7.6681 4.1312 1.5029 5.1255
(p<0.01) (p<0.05) NS (p<0.01)
120 minutes 2.8189 4.8497 6.9402 49.398
(p<0.05) (p<0.01) (p< 0.001) (p< 0.001)
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RAW DATA
TIME COURSE OF ATTACHMENT TO SUBSTRATE COATED AND 
UNCOATED CULTURE WELLS
Endothelium
Experiment 1 - Cells in 2nd Passage.
Initial count = 1.8 x 10^
Counts after trvpsinisation (x 10^ 1 ( = a)
Coating
_____________ Fn________ Col______ Lam_____ Uncoated
Time
(min)
15 6.0 2.4 1.4 0.6
30 9.2 3.8 1.4 0.4
60 5.2 5.2 2.4 3.2
120 4.4 7.4 3.8 2.8
Counts after wash (before trvpsinisation) (x 10^  ( = b)
Coating
_____________ Fn________ Col______Lam______Uncoated
Time
(min)
15 8.0 11.8 16.4 14.4
30 7.2 12.4 14.8 2.4
60 0.8 4.8 11.2 4.4
120 1.2 3.0 3.4 1.2
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Percentage adherence fa/a+b")
Coating
_____________ Fn________ Co]_______Lam_____ Uncoated
Time
(min)
15 43 17 8 4
30 56 23 9 14
60 87 52 18 42
120 79 71 53 70
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Experiment 2 - Cells in 2nd Passage
Initial count = 1.8 x 10^
Counts after trvpsinisation (x 10 1^ ( = a)
Coating
___________ Fn________ Col______ Lam_____ Uncoated
Time
(min)
15 3.4 2.0 0.4 0.4
30 9.0 4.0 1.6 2.2
60 8.2 4.8 2.2 5.4
120 9.8 6.6 4.0 7.4
Counts after wash ("before trvpsinisation* (x 10 1^ ( = b)
Coating
_____________ Fn________ Co]______ Lam_____ Uncoated
Time
(min)
15 3.6 11.8 12.8 8.8
30 6.4 12.4 11.6 8.8
60 1.6 3.6 7.8 4.8
120 1.6 2.0 4.4 2.8
Percentage adherence (a/a+bl
Time
(min)
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Coating
Fn________ Col______ Lam_____ Uncoated
15 49 4 3 4
30 58 24 12 20
60 84 57 32 53
120 86 77 48 73
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Experiment 3 - Cells in 2nd Passage
Initial count = 2.2 x 10^
Counts after trvpsinisation (x 10^  ( = a)
Coating
_____________ Fn________ Col______ Lam_____ Uncoated
Time
(min)
15 7.6 2.2 0.4 1.0
30 8.4 2.6 1.6 2.6
60 14.4 9.2 4.6 4.0
120 11.2 5.0 2.8 7.8
Counts after wash fbefore trvpsinisation^ (x 10^  ( = b)
Coating
_____________ Fn________ Col______ Lam_____ Uncoated
Time
(min)
15 8.4 14.4 18.4 20.0
30 7.6 12.4 • 13.2 9.6
60 2.4 8.0 12.0 4.4
120 0.8 2.0 3.2 2.0
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Percentage adherence (a/a+bl
Time
(min)
Coating
Fn__________Col________ Lam______ Uncoated
5 48 13 2 5
30 53 17 11 21
60 86 53 28 48
120 93 71 47 80
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b. Mesothelium
Experiment 1 - Cells in 4th Passage
Initial count = 2.26 x 10^
Counts after trvpsinisation (x 10^  ( = a)
Coating
______________ Fn__________Col_______ Lam______ Uncoated
Time
(min)
15 4.0 1.0 0.6 0.4
30 4.8 2.6 2.0 1.6
60 7.4 3.2 3.0 1.8
120 5.6 4.0 4.4 3.0
Counts after wash (before trvosinisation) (x 10^ 1 ( = b)
Coating
Fn Col Lam Uncoat<
Time
(min)
15 11.6 25.2 19.2 13.2
30 5.4 11.2 22.8 10.0
60 5.6 4.4 23.6 6.0
120 1.6 2.4 10.4 4.4
Percentage adherence (a/a+b'i
Coating
Fn Col Lam Uncoated
Time
(min)
15 26 4 3 3
30 47 19 8 14
60 57 42 11 23
120 78 63 30 41
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Experiment 2 - Cells in 5th Passage
Initial count = 1.9 x 10^
Counts after trvpsinisation (x 10 1^ ( = a)
Coating
Fn Col Lam Uncoated
Time
(min)
15 4.8 1.2 0.4 0.1
30 4.4 3.8 1.6 1.8
60 4.6 3.0 2.2 2.4
120 6.4 5.6 2.8 6.2
Counts after wash (before trvDsinisationl (x 10^ 1 ( = bl
Fn
Coating
Col Lam Uncoated
Time
(min)
15 11.6 12.6 8.0 14.0
30 7.6 22.0 7.8 10.8
60 4.0 6.8 8.0 4.4
120 3.2 4.0 5.2 6.4
Percentage adherence (a/a+b) 
Fn
Coating
Col Lam Uncoated
Time
(min)
15 29 9 5 1
30 37 15 17 14
60 53 31 22 35
120 67 58 35 49
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Experiment 3 - Cells in 2nd Passage
Initial Count = 9.2 x 10^
Counts after trvpsinisation (x 10 1^ ( = a)
Coating
Fn Col Lam Uncoated
Time
(min)
15 2.4 0.4 0.4 0.2
30 2.2 1.0 0.4 0.8
60 2.8 1.6 1.2 1.2
120 3.0 3.4 1.6 2.8
Counts after wash (before trvDsinisation) (x 10^ 1 ( = b)
Fn Col
Coating
Lam Uncoated
Time
(min)
15 4.8 8.8 7.6 3.0
30 4.0 6.0 6.4 6.0
60 1.6 2.4 4.8 2.4
120 1.2 2.8 3.6 1.6
Percentage adherence (a/a+b)
Fn Col
Coating
Lam Uncoated
Time
(min)
15 33 4 5 6
30 35 14 6 12
60 64 40 20 33
120 71 55 31 64
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APPENDIX 2
ADHESION OF ENDOTHELIAL CELLS TO ePTFE
Coating
Expt. No.
Fn. £ol Lam Uncoated PC
1. 76 56 50 14 32
2. 66 48 46 16 42
3. 69 64 48 21 43
4. 63 62 55 14 36
5. 33 50 55 30 30
6. 27 37 31 30 44
7. 31 50 31 14 46
8. 26 33 32 12 30
9. 28 25 14 14 48
10. 46 46 38 13 30
Mean 46.5 47.1 40.0 17.8 . 38.1
SD 20.0 12.4 13.1 6.9 6.9
SEM 6.3 3.9 4.1 1.8 2.2
Fn = fibronectin coated ePTFE 
Col = collagen coated ePTFE 
Lam = Laminin coated ePTFE 
PC = pre-clotted ePTFE
Figures are percentages of the total number of seeded cells which remain
adherent one hour after seeding.
122
ADHESION OF MESOTHELIAL CELLS TO ePTFE 
Coating
ixpt. No.
Fn Col Lam Uncoated PC
1. 56 38 35 19 33
2. 52 41 32 48 14
3. 50 38 35 11 24
4. 60 32 57 16 18
5. 50 42 38 33 20
6. 58 66 45 21 14
7. 50 56 50 25 15
8. 62 32 38 28 23
9. 52 42 43 25 17
10. 54 42 42 27 21
Mean 54.4 42.9 41.5 25.3 19.9
SD 4.4 10.5 7.6 10.1 5.8
SEM 1.4 3.3 2.4 3.2 1.8
Fn = fibronectin coated ePTFE
Col == collagen coated ePTFE
Lam = Laminin coated ePTFE 
PC = pre-clotted ePTFE
Figures are percentages of the total number of seeded cells which remain 
adherent one hour after seeding.
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ADHESION OF ENDOTHELIAL CELLS TO ePTFE 
”PRE-WETTED” PRIOR TO SUBSTRATE COATING
Coating
Expt.No.
Fn Col Lam Uncoat
1. 31 67 79 43
2. 38 51 54 43
3. 50 54 38 24
4. 79 72 21 35
5. 38 35 55 23
6. 38 19 43 32
7. 43 50 35 27
8. 50 50 38 23
9. 50 38 57 35
10. 38 50 50 43
Mean 46.0 48.8 47.5 33.9
SD 12.7 15.5 15.2 8.3
SEM 4.0 4.9 4.8 2.6
Fn = fibronectin coated ePTFE .
Col =: collagen coated ePTFE
Lam = Laminin coated ePTFE 
PC = pre-clotted ePTFE
Figures are percentages of the total number of seeded cells which remain
adherent one hour after seeding.
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ADHESION OF MESOTHELIAL CELLS TO ePTFE 
"PRE-WETTED" PRIOR TO SUBSTRATE COATING
Coating
Expt.No.
Fn £ol Lam Uncoat
1. 52 58 45 38
2. 62 50 42 50
3. 57 62 50 33
4. 56 43 30 28
5. 55 50 38 26
6. 46 50 33 26
7. 63 44 44 31
8. 53 52 42 36
9. 43 48 36 32
10. 40 42 42 26
Mean 52.7 49.9 40.2 32.2
SD 7.7 6.3 5.6 7.8
SEM 2.4 2.0 3.0 2.5
Fn = fibronectin coated ePTFE 
Col = collagen coated ePTFE 
Lam = Laminin coated ePTFE 
PC = pre-clotted ePTFE
Figures are percentages of the total number of seeded cells which remain
adherent one hour after seeding.
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Raw Data for ePTFE adhesion experiments
Each flask containing approximately 2 x 10  ^ cells was used for 10 experiments 
carried out simultaneously, giving a seeding density of around 2 x 10  ^ per 
chamber. The actual number of cells used is indicated in the table. In order to 
allow for variation in the adhesion characteristics of cells from different donors, 
cells from any one donor were used for a maximum of two experiments in each 
substrate group.
a. Endothelium 
Fibronectin
No. Count after 
Trvpsim^ation
Count in 
Wa$h 
(xlCr)
Total
Count
(xlO^)
Retention
m
1. 1.6 0.5 2.1 76
2. 1.9 1.0 2.9 66
3. 1.8 0.8 2.6 69
4. 1.0 0.6 1.6 63
5. 0.5 .1.0 1.5 33
6. 0.3 0.8 1.1 27
7. 0.5 1.1 1.6 31
8. 0.5 1.4 1.9 26
9. 0.8 2.1 2.9 28
10. 1.1 1.3 2.4 46
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Collagen type 4
No. Count after 
Trvpsim^ation
Count in 
Wash 
(xlO5)
Total
Count
(xlO^)
Retention
(%)
1. 1.4 1.1 2.5 56
2. 1.3 1.4 2.7 48
3. 1.4 0.8 2.2 64
4. 0.8 0.5 1.3 62
5. 1.0 1.0 2.0 50
6. 1.1 1.9 3.0 37
7. 1.0 1.0 2.0 50
8. 0.8 1.6 2.4 33
9. 0.6 1.8 2.4 25
10. 1.1 1.3 2.4 46
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Laminin
No. Count after 
Trvpsim^ation
Count in 
Wash 
(xlO5)
Total
Count
(xlO^)
Retention
(%)
1. 1.1 1.1 2.2 50
2. 1.1 1.3 2.4 46
3. 1.0 1.1 2.1 48
4. 0.6 0.5 1.1 55
5. 0.6 0.5 1.1 55
6. 0.5 1.1 1.6 31
7. 0.5 1.1 1.6 31
8. 1.0 2.1 3.1 32
9. 0.3 1.8 2.1 14
10. 0.6 1.0 1.6 38
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Uncoated
No. Count after Count in Total Retention
Trvpsini&ation Wash Count m(xlO^) (xlCr) (xlO^)
1. 0.3 1.8 2.1 14
2. 0.5 2.6 3.1 16
3. 0.3 1.1 1.4 21
4. 0.3 1.8 2.1 14
5. 0.6 1.4 2.0 30
6. 0.6 1.4 2.0 30
7. 0.3 1.8 2.1 14
8. 0.3 2.2 2.5 12
9. 0.3 1.9 2.1 14
10. 0.3 2.1 2.4 13
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Pre-clotted
No. Count after 
Trvpsiru^ation
Count in 
Wash 
(xlCr)
Total
Count
(xlO5)
Retention
(%)
1. 0.6 1.3 1.9 32
2. 1.0 1.4 2.4 42
3. 1.0 1.3 2.3 43
4. 0.8 1.4 2.2 36
5. 0.8 1.9 2.7 30
6. 0.8 1.0 1.8 44
7. 1.1 1.3 2.4 46
8. 0.6 1.4 2.0 30
9. 1.0 1.1 2.1 48
10. 0.6 1.4 2.0 30
130
b. Mesothelium 
Fibronectin
No. Count after Countin Total Retention
Trvosinisation Wash Count (%)
J (xlO5) (xlCr) (xlO^)
1. 1.0 0.8 1.8 56
2. 1.1 1.0 2.1 52
3. 0.8 0.8 1.6 50
4. 1.0 0.6 1.6 60
5. 1.3 1.3 2.6 50
6. 1.8 1.3 3.1 58
7. 1.3 1.3 2.6 50
8. 1.3 0.8 2.1 62
9. 1.1 1.0 2.1 52
10. 1.3 1.1 2.4 54
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Collagen type 4
No. Count after 
Trvpsim^ation
Count in 
Wash 
(xlO5)
Total
Count
(xlO5)
Retention
(%)
1. 1.0 1.6 2.6 38
2. 1.1 1.6 2.7 41
3. 0.8 1.3 2.1 38
4. 0.6 1.3 1.9 32
5. 0.8 1.1 1.9 42
6. 1.9 1.0 2.9 66
7. 1.0 0.8 1.8 56
8. 0.6 1.3 1.9 32
9. 0.8 1.1 1.9 42
10. 1.3 1.8 3.1 42
132
Laminin
No. Count after Count in Total Retention
Trvpsini&ation Wa&h Count (%)
(xlO^) (xlCr) (xlO^)
1. 0.6 1.1 1.7 35
2. 0.6 1.3 1.9 32
3. 0.6 1.1 1.7 35
4. 0.8 0.6 1.4 57
5. 1.0 1.6 2.6 38
6. 1.3 1.6 2.9 45
7. 1.1 1.1 2.2 50
8. 0.8 1.3 2.1 38
9. 1.0 1.3 2.3 43
10 0.8 1.1 1.9 42
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Uncoated
No. Count after 
Trvpsim^ation
Count in 
Wash 
(xlCr)
Total
Count
(xlO^)
Retenti
(%)
1. 0.3 1.3 1.6 19
2. 1.3 1.4 2.7 48
3. 0.2 1.6 1.8 11
4. 0.5 2.7 3.2 16
5. 0.8 1.6 2.4 33
6. 0.6 2.2 2.8 21
7. 0.6 1.8 2.4 25
8. 0.5 1.3 oo 28
9. 0.6 1.8 2.4 25
10. 0.6 1.6 2.2 27
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Pre-clotted
No. Count after 
Trvpsim^ation
Count in 
Wadi 
(xlCr)
Total
Count
(xlO5)
Retention
(%)
1. 0.5 1.0 1.5 33
2. 0.3 1.8 2.1 14
3. 0.5 1.6 2.1 24
4. 0.3 1.4 1.7 18
5. 0.4 1.6 2.0 20
6. 0.3 1.8 2.1 14
7. 0.3 1.7 2.0 15
8. 0.6 2.0 2.6 23
9. 0.2 1.0 1.2 17
10. 0.4 1.5 1.9 21
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c. Endothelium - ePTFE pre-wetted prior to coating 
Fibronectin
No. Count after 
Trvpsim^ation
Count in 
Wash 
(xlCr)
Total
Count
(xlO^)
Retention
(%)
1. 0.5 1.1 1.6 31
2. 1.0 1.6 2.6 38
3. 0.8 0.8 1.6 50
4. 1.1 0.3 1.4 79
5. 0.3 0.5 0.8 38
6. 0.5 0.8 1.3 38
7. 1.0 1.3 2.3 43
8. 1.0 1.0 2.0 50
9. 0.6 0.6 1.2 50
10. 0.6 1.0 1.6 38
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Type 4 Collagen
No. Count after 
Trvpsim^ation
Count in 
Wash 
(xlCr)
Total
Count
(xlO^)
Retention
(%)
1. 1.0 0.5 1.5 67
2. 1.9 1.8 3.7 51
3. 1.3 1.1 2.4 54
4. 1.3 0.5 1.8 72
5. 0.6 1.1 1.7 35
6. 0.5 2.2 2.7 19
7. 1.1 1.1 2.2 50
8. 1.0 1.0 2.0 50
9. 0.8 1.3 2.1 38
10. 0.6 0.6 1.2 50
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Laminin
No. Count after 
Trvpsim^ation
Count in 
Wa$h 
(xl(r)
Total
Count
(xlO^)
Retention
(%)
1. 1.1 0.3 1.4 79
2. 1.3 1.1 2.4 54
3. 1.0 1.6 2.6 38
4. 0.6 2.2 2.8 21
5. 0.6 0.5 1.1 55
6. 0.6 0.8 1.4 43
7. 0.6 1.1 1.7 35
8. 0.6 1.0 1.6 38
9. 1.3 1.0 2.3 57
10. 0.6 0.6 1.2 50
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Uncoated
No. Count after 
Trvpsinpation
Count in 
Wash 
(xl(r)
Total
Count
(xlO^)
Retention
(%)
1. 0.6 0.8 1.4 43
2. 0.6 0.8 1.4 43
3. 0.5 1.6 2.1 24
4. 0.6 1.1 1.7 35
5. 0.3 1.0 1.3 23
6. 0.6 1.3 1.9 32
7. 0.6 1.6 2.2 27
8. 0.3 1.0 1.3 23
9. 0.6 1.1 1.7 35
10. 0.6 0.8 1.4 43
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d. Mesothelium - ePTFE pre-wetted prior to coating 
Fibronectin
No. Count after 
Trvpsim^ation
Count in 
Waah 
(xl(r)
Total
Count
(xlO^)
Retention
(%)
1. 1.1 1.0 2.1 52
2. 1.6 1.0 2.6 62
3. 1.6 1.2 2.8 57
4. 1.3 1.0 2.3 56
5. 1.1 0.9 2.0 55
6. 1.2 1.4 2.6 46
7. 1.7 1.0 2.7 63
8. 1.0 0.9 1.9 53
9. 0.9 1.1 2.0 43
10. 0.6 0.9 1.5 40
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Collagen type 4
No. Count after Count in Total Retention
TrvDsinisation Wash Count (%)
1 (xl(r) (xlCr) (xlO^)
1. 1.9 1.4 3.3 58
2. 1.4 1.4 2.8 50
3. 1.3 0.8 2.1 62
4. 1.0 1.3 2.3 43
5. 1.0 1.0 2.0 50
6. 0.8 0.8 1.6 50
7. 1.1 1.4 2.5 44
8. 1.1 1.0 2.1 52
9. 1.0 1.1 2.1 48
10. 0.8 1.1 1.9 42
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Laminin
No. Count after Count in Total Retention
Trvosinisation Wash Count (%)
" (xl(P) (xl(r) (xlO5)
1. 1.3 1.6 2.9 45
2. 1.0 1.4 2.4 42
3. 1.3 1.3 2.6 50
4. 0.6 1.4 2.0 30
5. 0.6 1.0 1.6 38
6. 0.8 1.6 2.4 33
7. 1.1 1.4 2.5 44
8. 0.8 1.1 1.9 42
9. 0.8 1.4 2.2 36
10. 0.8 1.1 1.9 42
V
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Uncoated
No. Count after Count in Total Retention
TrvDsinisation Wash Count m ^ (xlO5) (xlCr) (xlO^)
1. 1.3 2.1 3.4 38
2. 0.8 0.8 1.6 50
3. 0.5 1.0 1.5 33
4. 0.5 1.3 00 28
5. 0.5 1.4 1.9 26
6. 0.5 1.4 1.9 26
7. 0.5 1.1 1.6 31
8. 0.8 1.4 2.2 36
9. 0.6 1.3 1.9 32
10. 0.5 1.4 1.9 26
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T values for ePTFE attachment studies
Uncoated eFl'FH versus substrate coated ePTFE
a. Endothelium
Pre-clot
6.5786
(p< 0.001)
Fibronectin Collagen
4.2898
(p< 0.001)
6.5294
(p< 0.001)
Laminin
4.7414
(p< 0.001)
b. Mesothelium
Pre-clot
1.4662
NS
Fibronectin Collagen
8.3562
(p< 0.001)
3.8201
(p< 0.001)
Laminin
4.0529
(p< 0.001)
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T values for comparison of endothelial attachment to ePTFL untreated and pre­
treated with alcohol
Fibronectin Collagen Laminin Uncoated
0.06674
NS
0.27083
NS
1.1819 4.7170
NS (p< 0.001)
T values for comparison of mesothelial attachment to ePTFE untreated and pre­
treated with alcohol
Fibronectin Collagen Laminin Uncoated
0.60618
NS
1.8078
NS
0.43547
NS
1.7098
NS
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Comparison of different substrates (one way analysis of 
variance)
a. Endothelium
Comparison between attachment rates to fibronectin, 
collagen, laminin coated and pre-clotted ePTFE:
F = 1.0703 
Not Significant
b. Mesothelium
Comparison between attachment rates to fibronectin, 
collagen, laminin coated and pre-clotted ePTFE:
F = 37.501
(p< 0.001)
Comparison between attachment rates to fibronectin, 
collagen, and laminin coated ePTFE:
F = 8.0221
(p<0.01)
T value for attachment to fibronectin compared to collagen type 4:
3.1943 (p < 0.01).
T value for attachment to fibronectin compared to laminin:
4.6452 (p< 0.001).
T value for attachment to pre-clotted compared to uncoated ePTFE:
1.4662 (N.S.).
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APPENDIX 3
ENDOTHELIAL ATTACHMENT TO GRAFT SEGMENTS AS 
MEASURED BY INDIUM LABELLING OF CELLS
Coating
Expt.No.
Fn Col Lam Uncoated PC
1. 43 20 35 0 30
2. 34 13 24 1 38
3. 29 78 53 28 42
4.. 69 42 58 9 25
5. 43 47 5 16 45
Mean 43.6 40.0 35 10.8 36.0
SD 15.4 25.6 21.6 11.6 8.3
SEM 6.9 11.4 2.2 5.2 3.7
Fn = fibronectin coated ePTFE 
Col = collagen coated ePTFE 
Lam = Laminin coated ePTFE 
PC = pre-clotted ePTFE
Figures are percentages of the total number of seeded cells which remain
adherent one hour after seeding.
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MESQTHELIAL ATTACHMENT TO GRAFT SEGMENTS AS 
MEASURED BY INDIUM LABELLING OF CELLS
Coating
Expt.No.
Fn Col Lam Uncoated PC
1. 79 65 31 0 16
2. 68 35 54 16 22
3. 63 33 34 0 28
4. 75 68 59 10 12
5. 50 38 45 8 14
Mean 67.0 47.8 44.6 6.8 18.4
SD 11.3 17.2 12.2 6.9 6.5
SEM 5.1 7.7 5.5 3.1 2.9
Fn = fibronectin coated ePTFE 
Col = collagen coated ePTFE 
Lam = Laminin coated ePTFE 
PC = pre-clotted ePTFE
Figures are percentages of the total number of seeded cells which remain
adherent one hour after seeding.
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RAW DATA FOR INDIUM LABELLING EXPERIMENTS
Confluent cells from one flask were used for two experiments (giving a seeding 
density of approximately 10  ^cells per graft segment, assuming 2 x 10  ^per flask). 
Each flask of cells was trypsinised, labelled, centrifuged, labelling efficiency 
measured, and the suspension divided into two, ready for seeding into two graft 
segments. The initial radioactivity counts in the following tables were measured 
after the suspension had been divided into two, and immediately prior to seeding. 
Graft segments were 5cm long by 6mm internal diameter, 
giving a surface area of approximately 9.4cm^. Seeding density per cm^ was 
therefore 1.06 x 10 ,^ i.e. just over confluent density.
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1. Endothelium
a. Fibronectin coated grafts 
Experiment 1
Initial radioactivity counts (cpm) 
Counts in cell pellet 
Labelling efficiency
72612
45924
63%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour
16332
23040
39372
10%
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft 
Percentage retention
90% of 39372 
35436
20304
35436 - 20304 
15132
15132/35436x100
43%
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Experiment 2
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
37560
4884
13%
Counts in graft after 1 hour’s incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
996
3492
4488
62%
38% of 4488 
1705
1128
1705 - 1128 
577
577/1705x100
34%
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Experiment 3
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
64428
27060
42%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
3924
15876
19800
41%
59% of 19800 
11688
8244
11688 - 8244 
3444
3444/11688x100
29%
Experiment 4
Initial radioactivity counts (cpm) 36768
Counts in cell pellet 10296
Labelling efficiency 28%
Counts in graft after 1 hour's incubation 5268
Counts in effluent from graft 3588
8856
Spontaneous leak over 1 hour 20%
Total cellular counts after 1 hour = 80% of 8856
7084
Counts in cell pellet after centrifugation
of effluent = 2184
Therefore cell counts in graft
Percentage retention
7085 - 2184 
4901
4901/7084x100
153
Experiment 5
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
44892
16608
37%
9120
6012
15132
33%
67% of 15132 
10138
5796
10138 - 5796 
4342
4342/10138 x 100 
43%
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b. Collagen type 4 coated grafts 
Experiment 1
Initial radioactivity counts (cpm)
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
53832
33912
63%
5520
24024
29544
10%
90% of 29544 
26590
21384 
26590 - 21384 
5206
5206/26590x100
20%
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Experiment 2
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
75396
37116
49%
10212
20244
30456
41%
59% of 30456 
17969
15552
17969 - 15552 
2417
2417/17969x100
13%
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Experiment 3
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
63168
38532
61%
25620
8508
34128
32%
68% of 34128 
23207
5064
23207 - 5064 
18143
18143/23207x100
78%
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Experiment 4
Initial radioactivity counts (cpm)
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
90144
26700
30%
9744
11124
20868
31%
69% of 20868 
14399
8376
14399 - 8376 
6023
6023/14399 x 100 
42%
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Experiment 5
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
10969
31092
28%
18420
15828
34248
43%
57% of 34248 
19521
10296
19521 -10296 
9225
9225/19521x 100 
47%
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c. Laminin coated grafts
Initial radioactivity counts (cpm) 
Counts in cell pellet 
Labelling efficiency
37572
4884
13%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
696
2904
3600
62%
38% of 3600 
1368
888
1368 - 888 
480
480/1368 x 100 
35%
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Experiment 2
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
74856
37128
50%
12744
16200
28944
41%
59% of 28944 
17077
12900
17077 -12900 
4177
4177/17077x100
24%
161
Experiment 3
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
55860
23460
42%
5448
10920
16368
41%
59% of 16368 
9657
4584
9657 - 4584 
5073
5073/9657x100
53%
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Experiment 4
Initial radioactivity counts (cpm)
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
83796
24300
29%
11568
9564
21132
31%
69% of 21132 
14581
6192
14581 - 6192 
8389
8389/14581x 100 
58%
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Experiment 5
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
95814
26829
28%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
7128
18126
25254
43%
57% of 25254 
14395
13680
14395 - 13680 
715
715/14395x100
5%
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d. Uncoated grafts 
Experiment 1
Initial radioactivity counts (cpm) 78804
Counts in cell pellet 32448
Labelling efficiency 41%
Counts in graft after 1 hour's incubation 2184
Counts in effluent from graft 22524
24708
Spontaneous leak over 1 hour 47%
Total cellular counts after 1 hour = 53% of 24708
13095
Counts in cell pellet after centrifugation
of effluent = 17988
Therefore cell counts in graft
Percentage retention
13095 - 17988 
0 
0%
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Experiment 2
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
52416
17220
33%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
2352
10584
12936
37%
63% of 12936 
8150
8076
8150 - 8076 
74
74/8150x100
1%
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Experiment 3
Initial radioactivity counts (cpm)
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
57276
34932
61%
5268
22356
27624
32%
68% of 27624 
18784
13548
18784 - 13548 
5236
5236/18784x100
28%
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Experiment 4
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
65076
26676
41%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour
%
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
5184
14688
19872
31%
69% of 19872 
13712
12480
13712 -12480 
1232
1232/13712x100
9%
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Experiment 5
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
51432
/
20568
40%
7260
10944
18204
30%
70% of 18204 
12742
10704
12742 -10704 
2038
2038/12742x100
16%
169
Pre-clotted Grafts 
Experiment 1
Initial radioactivity counts (cpm) 
Counts in cell pellet 
Labelling efficiency
1944
5316
7260
57%
43% of 7260 
3122
2184
3122 - 2184 
938
938/3122x100
30%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
56448
12984
23%
170
Experiment 2
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
54504
15096
28%
5340
7584
12924
20%
80% of 12924 
10339
6408
10339 - 6408 
3931
3931/10339x100
38%
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Experiment 3
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
44892
16608
37%
6516
8664
15180
33%
67% of 15180 
10171
5904
10171 - 5904 
4267
4267/10171x 100 
42%
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Experiment 4
Initial radioactivity counts (cpm)
Counts in cell pellet
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
90144
26700
30%
5628
18780
24408
31%
69% of 24408 
16842
12624
16842-12624
4218
4218/16842x100
25%
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Experiment 5
Initial radioactivity counts (cpm)
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
91380
26700
29%
9900
14604
24504
31%
69% of 24504 
16908
9216
16908 - 9216 
7692
7692/16908x100
45%
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2. MESOTHELIUM 
a Fibronectin coated grafts 
Experiment 1
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft 
Percentage retention
73224
35652
49%
18456
7404
25860
27%
73% of 25860 
18878
3888
18878 - 3888 
14990
14990/18878x100
79%
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Experiment 2
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
58068
44712
77%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
25248
13464
38712
24%
76% of 38712 
29421
9312
29421 - 9312 
20109
20109/29421x 100 
68%
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Experiment 3
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
53832
19920
37%
8868
6432
15300
11%
89% of 15300 
13617
4992
13617 - 4992 
8625
8625/13617 x 100 
63%
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Experiment 4
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
32280
15492
48%
6576
3024
9600
43%
57% of 9600 
5472
1368
5472 - 1368 
4104
4104/5472x100
75%
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Experiment 5
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
65664
45312
69%
22284
17364
39648
36%
64% of 39648 
25374
12660
25374 -12660 
12714
12714/25374x100
50%
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Collagen coated grafts
Experiment 1 
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
106080
44616
42%
18000
16236
34236
34%
66% of 34236 
22596
7824
22596 - 7824 
14772
14772/22596 x 100 
65%
Experiment 2
Initial radioactivity counts 80220
Counts in cell pellet 61212
Labelling efficiency 76%
Counts in graft after 1 hour's incubation 18000
Counts in effluent from graft 33120
51120
Spontaneous leak over 1 hour 45%
Total cellular counts after 1 hour = 55% of 51120
28116
Counts in cell pellet after centrifugation
of effluent = 18228
Therefore cell counts in graft
Percentage retention
28116 -18228 
9888
9888/28116x100
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Experiment 3
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
44400
21492
48%
5016
8100
13116
43%
57% of 13116 
7476
5004
7476 - 5004 
2472
2472/7476x100
33%
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Experiment 4
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
59532
41076
69%
25716
13128
38844
24%
76% of 38844 
29521
9372
29521 - 9372 
20149
20149/29521x 100 
68%
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Experiment 5
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
56556
13008
23%
2148
5412
7560
39%
61% of 7560 
4612
2856
4612 - 2856 
1756
1756/4612x100
38%
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Laminin coated grafts 
Experiment 1
Initial radioactivity counts 80220
Counts in cell pellet 61212
Labelling efficiency 76%
Counts in graft after 1 hour's incubation 12084
Counts in effluent from graft 37164
49248
45%
55% of 49248 
27086
18720
27086 - 18720 
8366
8366/27086x100
31%
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
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Experiment 2
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
53832
19920
37%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
7344
7680
15024
11%
89% of 15024 
13371
6084
13371 - 6084 
7287
7287/13371x 100 
54%
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Experiment 3
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell counts in graft
Percentage retention
100236
83064
69%
9060
32064
41124
36%
64% of 41124 
26319
17364
26319 - 17364 
8955
8955/26319x100
34%
Experiment 4
Initial radioactivity counts 31800
Counts in cell pellet 14628
Labelling efficiency 46%
Counts in graft after 1 hour's incubation 6960
Counts in effluent from graft 3300
10260
Spontaneous leak over 1 hour 27%
Total cellular counts after 1 hour = 73% of 10260
7490
Counts in cell pellet after centrifugation
of effluent = 3072
Therefore cell counts in graft
Percentage retention
7490 - 3072 
4418
4418/7490x100
59%
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Experiment 5
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 17844
Counts in effluent from graft 33588
51432
36%
64% of 51432 
32916
Counts in cell pellet after centrifugation
of effluent = 18108
32916 -18108 
14808
14808/32916x100 
45%
Therefore cell count in graft
Percentage retention
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
102468
58404
57%
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Uncoated grafts
Experiment 1
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
81804
56448
69%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell count in graft
Percentage retention
5736
44052
49788
36%
64% of 49788 
31864
33528
31864 - 33528 
0 
0 
0%
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Experiment 2
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
62748
48312
77%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell count in graft
Percentage retention
9912
31032
40944
24%
76% of 40944 
31114
26280
31114 - 26280 
4834
4834/31114x100
16%
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Experiment 3
Initial radioactivity counts 94824
Counts in cell pellet 65184
Labelling efficiency 69%
Counts in graft after 1 hour's incubation 3408
Counts in effluent from graft 46044
49452
24%
76% of 49452 
37584
Counts in cell pellet after centrifugation
of effluent = 41436
Therefore cell count in graft
Percentage retention
37584 - 41436
0
0%
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
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Experiment 4
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
81900
42984
57%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell count in graft
Percentage retention
9144
30552
39696
23%
67% of 39696 
26596
23940
26596 - 23940 
2656
2656/26596x100
10%
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Experiment 5
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
89940
37776
42%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell count in graft
Percentage retention
10368
25920
36288
36%
67% of 36288 
24313
22368
24313 - 22368 
1945
1945/24313x100
8%
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Pre-clotted grafts
Experiment 1
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
67656
15564
23%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
4212
8064
12276
Spontaneous leak over 1 hour
Total cellular counts after 1 hour
36%
64% x 12276 
7857
Counts in cell pellet after centrifugation 
of effluent 6600
Therefore cell count in graft
Percentage retention
7857 - 6600 
1257
1257/7857x100
16%
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Experiment 2
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
75564
56520
68%
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell count in graft
Percentage retention
21192
33624
54816
24%
76% of 54816 
41660
32616
41660 - 32616 
9044
9044/41660x100 
• 22%
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Experiment 3
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell count in graft
Percentage retention
65784
39468
60%
10752
25092
35844
30%
70% of 35844 
25091
18084
25091 -18084 
7007
7007/25091x 100 
28%
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Experiment 4
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell count in graft
Percentage retention
72144
43284
60%
7128
28896
36024
30%
70% of 36024 
25217
22224
25217 - 22224 
2993
2993/25217x100
12%
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Experiment 5
Initial radioactivity counts 
Counts in cell pellet 
Labelling efficiency
Counts in graft after 1 hour's incubation 
Counts in effluent from graft
Spontaneous leak over 1 hour 
Total cellular counts after 1 hour
Counts in cell pellet after centrifugation 
of effluent
Therefore cell count in graft
Percentage retention
79032
48996
62%
12816
33684
46500
34%
66% of 46500 
30690
26280
30690 - 26280 
4410
4410/30690x100
14%
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T values for indium labelling studies. Comparison of uncoated with substrate 
coated grafts
a. Endothelium 
Pre-clotted 
3.9505
(p<0.01)
Fibronectin Collagen
3.8041
(p<0.01)
2.3231
(p<0.05)
Laminin
2.2071
NS
b. Mesothelium
Pre-clotted
2.7363 
(p < 0.05)
Fibronectin Collagen
10.167
(p< 0.001)
4.9469
(p<0.01)
Laminin
6.0305
(p< 0.001)
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Comparison of different substrates (one wav analysis of variance")
a. Endothelium
Comparison between attachment rates to fibronectin, collagen, laminin coated 
and pre-clotted graft segments:
F = 0.21789 
Not significant
b. Mesothelium
Comparison between attachment rates to fibronectin, collagen, laminin coated 
and pre-clotted graft segments:
F = 12.998
(p< 0.001)
Comparison between attachment rates to fibronectin, collagen and laminin 
coated graft segments:
F = 3.8456 
(not significant)
Comparison between attachment rates to pre-clotted and collagen of laminin 
coated graft segments:
F = 8.0147
(p<0.01)
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APPENDIX 4
Cell numbers, labelling efficiency and initial attachment rates for flow 
experiments (6 experiments)
25 ml /minute
Cell number Labelling efficiency (%) Attachment]^)
(x 10°)
2.33 44.2 77.0
1.53 19.7 78.2
3.30 62.3 71.3
3.30 67.1 63.0
2.09 63.6 87.3
2.40 61.0 93.9
100 ml/minute
Cell number Labelling efficiency (%) Attachment (%)
Fio6)
2.29 61.8 75.6
3.00 68.2 85.5
3.67 61.4 71.4
3.97 81.3 67.7
2.13 83.3 94.4
2.23 83.3 80.7
202
200 ml/minute 
Cell number
(Ho5)
2.18
1.69
2.97
3.58
2.84
5.91
Labelling efficiency (%)
70.2
75.3 
68.8
64.3
71.7
81.8
Attachment (%)
55.9
80.0
79.5
77.3
86.5
83.3
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Cell retention after flow at 25 ml/minute (6 experiments")
°1 °2 5 10 20 30 40 50 60_1
100 87.5 84.3 83.2 82.2 80.8 79.4 78.2 77.4
100 94.7 94.0 93.9 91.2 89.6 87.5 87.7 86.6
100 99.6 99.1 99.3 97.3 94.3 94.5 93.4 91.6
100 94.8 91.6 92.3 90.4 89.7 88.7 88.9 87.9
100 96.7 95.5 95.8 94.6 93.7 94.4 94.2 94.1
100 95.5 85.8 83.7 81.8 79.7 78.8 77.4 76.7
Mean 94.8 91.7 91.4 89.6 88.0 87.2 86.6 85.7
SD 4.0 5.7 6.6 6.4 6.3 6.9 7.3 7.2
SEM 1.6 2.3 2.7 2.4 2.6 2.8 2.4 2.4
Cell retention after flow at 100 ml/minute (6 experiments!
°1 O0 5 10 20 30 40 50 60
100 89.2 85.9 84.9 83.0 81.3 81.0 80.0 79.4
100 92.9 91.9 91.2 89.7 88.7 87.7 87.7 86.8
100 83.3 83.0 81.7 79.2 77.0 75.7 74.9 74.6
100 84.5 80.6 78.5 76.9 76.4 76.1 75.5 73.6
100 95.6 95.7 96.0 94.5 93.7 93.5 93.3 93.1
100 96.0 94.5 93.5 93.1 92.2 91.7 91.2 90.2
Mean 90.3 88.6 87.6 86.1 84.9 84.3 83.5 82.9
SD 5.5 6.3 7.0 7.4 7.7 7.8 8.2 8.5
SEM 2.2 2.6 2.8 3.0 3.1 3.2 3.3 3.5
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Cell retention after flow at 200 ml/minute (6 experiments')
°1 Oo 5 10 20 30 40 50 60
100
L---
95.1 96.7 95.3 94.9 93.5 92.4 91.9 90.7
100 83.9 83.6 82.1 80.7 79.1 78.2 76.7 76.5
100 80.1 75.4 71.2 69.3 68.0 66.4 66.0 64.9
100 93.0 88.8 86.7 84.2 82.8 80.6 78.7 78.1
100 94.3 93.2 92.7 91.6 90.9 87.9 87.6 86.5
100 92.4 89.5 88.1 86.7 84.3 . 83.3 82.1 80.7
Mean 89.8 87.9 86.0 84.6 83.1 81.5 80.5 79.6
SD 6.2 7.5 8.6 9.0 9.1 9.0 9.1 8.9
SEM 2.5 3.1 3.5 2.4 3.7 3.7 2.4 3.7
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DATA FOR FLOW EXPERIMENTS 
Experiment 1-25 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
02 94785 100
02 82944 87.5
5 79995 84.3
10 78893 83.2
20 77967 82.2
30 76571 80.8
40 75243 79.4
50 74129 78.2
60 73318 77.4
Experiment 2-25 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
01 73295 100
02 69412 94.7
5 68912 94.0
10 68871 93.9
20 66847 91.1
30 65674 89.6
40 64157 87.5
50 64291 87.7
60 60525 86.6
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Experiment 3 -25  ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
0-l 79880 100
02 79575 99.6
5 79199 99.1
10 79345 99.3
20 77708 97.3
30 75304 94.3
40 75460 94.5
50 74624 93.4
60 73179 . 91.6
Experiment 4-25 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
0X 91962 100
02 87215 94.8
5 84207 91.6
10 84908 92.3
20 83102 90.4
30 82499 89.7
40 81641 88.7
50 81771 88.9
60 80902 87.9
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Experiment 5 -25  ml /minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
01 73195 100
02 70768 96.7
5 69923 98.8
10 70122 95.8
20 69272 94.6
30 68597 93.7
40 69166 93.5
50 68963 92.8
60 68899 94.1
Experiment 6 - 25 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
01 88235 100
02 84249 95.5
5 . 75663 85.8
10 73871 83.7
20 72144 81.8
30 70321 79.7
40 69526 78.8
50 68250 77.4
60 67644 76.7
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Experiment 7 -100 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
01 91176 100
02 81370 89.2
5 78347 85.9
10 77422 84.9
20 75712 83.0
30 74115 81.3
40 73879 81.0
50 72936 80.0
60 72432 79.4
Experiment 8 -100 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
01 93192 100
02 86572 92.9
5 85682 91.9
10 84979 91.2
20 83581 89.7
30 82703 88.7
40 81755 87.7
50 81801 87.7
60 80925 86.8
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Experiment 9 -100 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
01 73575 100
02 61328 83.3
5 61097 83.0
10 60128 81.7
20 58281 79.2
30 56669 77.0
40 55758 75.7
50 55110 74.9
60 54890 . 74.6
Experiment 10 -100 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
0X 89076 100
02 75273 84.5
5 71850 80.6
10 69915 78.5
20 68531 76.9
30 68055 76.4
40 67777 76.1
50 67291 75.5
60 65631 73.6
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Experiment 11 -100 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
0X 116432 100
02 111299 95.6
5 111464 95.7
10 111739 96.0
20 110043 94.5
30 109147 93.7
40 108884 93.5
50 108644 • 93.3
60 108417 93.1
Experiment 12-100 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
0X 103480 100
02 99357 96.0
5 97816 94.5
10 96770 93.5
20 96335 92.2
30 95370 92.2
40 94863 91.7
50 94339 91.2
60 93359 90.2
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Experiment 13 - 200 ml/minute
Time
(minutes)
Counts over graft 
(counts/minute)
Percentage of initial counts
°1 81514 100
°2 77558 95.1
5 78852 96.7
10 77717 95.3
20 77334 94.9
30 76210 93.5
40 75268 92.4
50 74892 91.9
60 73918 . 90.7
Experimnent 14 - 200 ml/minute
Time
(minutes)
Counts over graft 
(counts/minute)
Percentage of initial counts
°1 89848 100
°2 75375 83.9
5 75094 83.6
10 73786 82.1
20 72506 80.7
30 71058 79.1
40 70241 78.2
50 68952 76.7
60 68764 76.5
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Experiment 15 - 200 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
01 98679 100
02 79027 80.1
5 74416 75.4
10 70267 71.2
20 68421 69.3
30 67126 68.0
40 65544 66.4
50 65114 66.0
60 64020 . 64.9
Experiment 16 - 200 ml/minute
Time Counts over graft Percentage of initial counts
(minutes) (counts/minute)
01 98373 100
02 91496 93.0
5 87363 88.8
10 85325 86.7
20 82796 84.2
30 81428 82.8
40 80265 81.6
50 77423 78.7
60 76820 78.1
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Experiment 17 - 200 ml/minute
Time
(minutes)
Counts over graft 
(counts/minute)
Percentage of initial counts
°1 88319 100
°2 83368 94.4
5 82334 93.2
10 81941 92.8
20 80885 91.6
30 80241 90.9
40 77673 87.9
50 77395 87.6
60 76361 . 86.5
Experiment 18 - 200 ml/minute
Time
(minutes)
°1
°2
5
10
20
30
40
50
60
Counts over graft 
(counts/minute)
110584
102135
98941
97394
95862
93259
92170
90810
89256
Percentage of initial counts
100
92.4
89.5 
88.1
86.7
84.3
83.3 
82.1
80.7
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